<SEC-DOCUMENT>0001213900-20-043821.txt : 20201221
<SEC-HEADER>0001213900-20-043821.hdr.sgml : 20201221
<ACCEPTANCE-DATETIME>20201221163110
ACCESSION NUMBER:		0001213900-20-043821
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20201215
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201221
DATE AS OF CHANGE:		20201221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEKTAR THERAPEUTICS
		CENTRAL INDEX KEY:			0000906709
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943134940
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24006
		FILM NUMBER:		201404671

	BUSINESS ADDRESS:	
		STREET 1:		455 MISSION BAY BOULEVARD SOUTH
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
		BUSINESS PHONE:		4154825300

	MAIL ADDRESS:	
		STREET 1:		455 MISSION BAY BOULEVARD SOUTH
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INHALE THERAPEUTIC SYSTEMS INC
		DATE OF NAME CHANGE:	19980723

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INHALE THERAPEUTIC SYSTEMS
		DATE OF NAME CHANGE:	19940303
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea132008-8k_nektartherap.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:NKTR="http://nektartherapeutics.com/20201215">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_NKTR_nektartherapeutics.com_20201215 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20201215_20201215 -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0000906709 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:EntityCentralIndexKey">0000906709</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-12-15to2020-12-15" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="nktr-20201215.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-12-15to2020-12-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000906709</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-15</xbrli:startDate>
        <xbrli:endDate>2020-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Washington,
D.C.&#160;20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>FORM
<span id="xdx_90D_edei--DocumentType_c20201215__20201215_zOTQRRwRCw4d"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Pursuant
to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Date
of report&#160;(Date of earliest event reported): <span id="xdx_903_edei--DocumentPeriodEndDate_c20201215__20201215_zQkeHLYP6m8j"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 15, 2020</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90C_edei--EntityRegistrantName_c20201215__20201215_zxEXR7nr6xii"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:EntityRegistrantName">NEKTAR
THERAPEUTICS</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Exact
Name of Registrant as Specified in Charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20201215__20201215_z5jwFTVKOLS4"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityFileNumber_c20201215__20201215_zt9xfhy6iudg"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:EntityFileNumber">0-24006</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20201215__20201215_zLDEpzqjsFva"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:EntityTaxIdentificationNumber">94-3134940</ix:nonNumeric></span></b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(State
    or Other Jurisdiction<br />
    of Incorporation)</b></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Commission
    File Number)</b></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(IRS
    Employer<br />
    Identification No.)</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_906_edei--EntityAddressAddressLine1_c20201215__20201215_zP2Gt2lwaer4"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:EntityAddressAddressLine1">455
Mission Bay Boulevard South</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--EntityAddressCityOrTown_c20201215__20201215_zJYJBcGf1nH7"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:EntityAddressCityOrTown">San
Francisco</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20201215__20201215_zxyw8VO3FUje"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_90C_edei--EntityAddressPostalZipCode_c20201215__20201215_zZGyidB7fpzg"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:EntityAddressPostalZipCode">94158</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Address
of Principal Executive Offices and Zip Code)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Registrant&#8217;s
telephone number, including area code: <span id="xdx_907_edei--CityAreaCode_c20201215__20201215_zyrhHaFXyQ0l"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:CityAreaCode">(415)</ix:nonNumeric></span> <span id="xdx_907_edei--LocalPhoneNumber_c20201215__20201215_zyUYwSy5Wj55"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:LocalPhoneNumber">482-5300</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 26px"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--WrittenCommunications_c20201215__20201215_z1Phh9UVPnxd"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications
    pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 26px; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--SolicitingMaterial_c20201215__20201215_zDZoq2fwXaq3"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material
    pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 26px; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--PreCommencementTenderOffer_c20201215__20201215_ztEdbfEzvk6g"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 26px; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20201215__20201215_z1TWLNtvkdfa"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Securities
registered pursuant to Section 12(b) of the Act:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1.5pt solid; width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title
    of each class</b></span></td>
    <td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading
    symbol(s)</b></span></td>
    <td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name
    of each exchange on <br />
which registered</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--Security12bTitle_c20201215__20201215_zAd90azUFyc"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:Security12bTitle">Common Stock, $0.0001
    par value</ix:nonNumeric></span></span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--TradingSymbol_c20201215__20201215_zdlHryWUCa3f"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" name="dei:TradingSymbol">NKTR</ix:nonNumeric></span></span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--SecurityExchangeName_c20201215__20201215_z2zKhav6sHd6"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ Global Select
    Market</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Emerging
growth company&#160;<span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20201215__20201215_zHqcZOClQsHf"><ix:nonNumeric contextRef="From2020-12-15to2020-12-15" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
5.03. Amendment to Article of Incorporation or Bylaws; Change in Fiscal Year. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
December 15, 2020, the Board of Directors of Nektar Therapeutics (the &#8220;Company&#8221;) approved an amendment and restatement
of the Company&#8217;s amended and restated bylaws to designate the federal district courts of the United States of America as
the exclusive forum for any action asserting a claim arising under the Securities Act of 1933, as amended, unless the Company
consents in writing to the selection of an alternative forum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
foregoing description of the Company&#8217;s amended and restated bylaws is qualified in its entirety by reference to the amended
and restated bylaws of the Company, which are attached hereto as Exhibit 3.1 and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font: 10pt Times New Roman, Times, Serif"><b>Item 9.01</b></span> <span style="font: 10pt Times New Roman, Times, Serif"><b>Financial Statements and Exhibits</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>(d)
Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 8%"><span style="font: 10pt Times New Roman, Times, Serif"><i>Exhibit Number</i></span></td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left; width: 91%; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><i>Description</i></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font: 10pt Times New Roman, Times, Serif">3.1</span></td>
    <td>&#160;</td>
    <td><a href="ea132008ex3-1_nektartherap.htm"><span style="font: 10pt Times New Roman, Times, Serif">Amended and Restated Bylaws of Nektar Therapeutics, dated as of &#160;December 15, 2020</span></a></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 60%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 5%"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%"><span style="font: 10pt Times New Roman, Times, Serif">/s/
    Mark A. Wilson</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Mark A. Wilson</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><i>General Counsel and Secretary</i></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Date:&#160;&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">December 21, 2020 </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">2</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZi6YBXXSnRYtYRYqI22BHCbaZMok/PZK3NE0XDgPD4837nhATUdDGNMhwWVUlnLDtGu0RKrwho71i+Mi3uwzCrfBunGdtfZQFxch8utBBRf9lHNYZpGqm0pmSIBeZlLDci2Twc7I3U6P1RjegbQ1Hpo4Nes39SDjpD1lq+8g/IztDNuCmcrS/oGSq4EAv/SZ+OCjLXCSTOIkomJ7dUPN0nlpYN9iGLjdG/5v8ABZwRO4= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ea132008ex3-1_nektartherap.htm
<DESCRIPTION>AMENDED AND RESTATED BYLAWS OF NEKTAR THERAPEUTICS, DATED AS OF DECEMBER 15, 2020
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AMENDED AND RESTATED </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>BYLAWS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>OF </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NEKTAR THERAPEUTICS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(A DELAWARE CORPORATION) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(amended and restated as of December 15,
2020)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE I </B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>OFFICES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 1. REGISTERED OFFICE</B>. The
registered office of the corporation in the State of Delaware shall be as set forth in the Certificate of Incorporation of the
corporation, as amended from time to time (the &ldquo;<U>Certificate of Incorporation</U>&rdquo;).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 2. OTHER OFFICES</B>. The corporation
shall also have and maintain an office or principal place of business at such place as may be fixed by the Board of Directors,
and may also have offices at such other places, both within and without the State of Delaware as the Board of Directors may from
time to time determine or the business of the corporation may require.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE II </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CORPORATE SEAL </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 3. CORPORATE SEAL</B>. The corporate
seal shall consist of a die bearing the name of the corporation and the inscription, &ldquo;Corporate Seal-Delaware.&rdquo; Said
seal may be used by causing it or a facsimile thereof to be impressed or affixed or reproduced or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE III </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STOCKHOLDERS&rsquo; MEETINGS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 4. PLACE OF MEETINGS</B>. Meetings
of the stockholders of the corporation shall be held at such place, if any, either within or without the State of Delaware, as
may be designated from time to time by the Board of Directors.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 5. ANNUAL MEETINGS</B>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) The annual meeting of the stockholders
of the corporation, for the purpose of election of directors and for such other business as may lawfully come before it, shall
be held on such date and at such time as may be designated from time to time by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) At an annual meeting of the stockholders,
only such business shall be conducted as shall have been properly brought before the meeting. Stockholders seeking to nominate
persons for election to the Board of Directors must comply with paragraph (c)&nbsp;of this <U>Section&nbsp;5</U> or with <U>Section&nbsp;5A</U>,
and this paragraph (b)&nbsp;shall not be applicable to nominations except as expressly provided in paragraph (c)&nbsp;below or
<U>Section&nbsp;5A</U>, as applicable. To be properly brought before an annual meeting, business (other than nominations) must
be: (A)&nbsp;specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board of Directors,
(B)&nbsp;otherwise properly brought before the meeting by or at the direction of the Board of Directors or any committee thereof,
or (C)&nbsp;otherwise properly brought before the meeting in compliance with this <U>Section&nbsp;5</U> by a stockholder of the
corporation who was a stockholder of record of the corporation at the time notice provided for in this <U>Section&nbsp;5</U> is
delivered to the Secretary of the corporation and who is entitled to vote at the meeting. For such business to be properly brought
before an annual meeting by a stockholder pursuant to clause (C)&nbsp;of this paragraph (b), the stockholder must have given timely
notice thereof in writing to the Secretary of the corporation and any such proposed business must constitute a proper matter for
stockholder action. To be timely, a stockholder&rsquo;s notice must be delivered to, or mailed and received by, the Secretary of
the corporation at the principal executive offices of the corporation not later than the close of business on the sixtieth (60th)
day, nor earlier than the close of business on the ninetieth (90th) day, prior to the first anniversary of the preceding year&rsquo;s
annual meeting; <U>provided</U>, <U>however</U>, in the event the date of the annual meeting is more than thirty (30)&nbsp;days
before or more than thirty (30)&nbsp;days after such anniversary date, notice by the stockholder to be timely must be so received
not earlier than the close of business on the ninetieth (90th) day prior to such date of the annual meeting and not later than
the close of business on the later of the sixtieth (60th) day prior to such annual meeting or the close of business on the tenth
(10th) day following the day on which public announcement of the date of such meeting is first made by the corporation. In no event
shall the public announcement of an adjournment or postponement of an annual meeting commence a new time period (or extend any
time period) for the giving of a stockholder&rsquo;s notice as described above. A stockholder&rsquo;s notice to the Secretary of
the corporation shall set forth as to each matter the stockholder proposes to bring before the annual meeting: (i)&nbsp;a brief
description of the business desired to be brought before the annual meeting, the text of the proposal or business (including the
text of any resolutions proposed for consideration and, in the event that such business includes a proposal to amend the Bylaws,
the language of the proposed amendment) and the reasons for conducting such business at the annual meeting, (ii)&nbsp;the name
and address, as they appear on the corporation&rsquo;s books, of the stockholder proposing such business, (iii)&nbsp;the class
and number of shares of capital stock of the corporation which are owned beneficially and of record by the stockholder, (iv)&nbsp;any
material interest in such business of such stockholder and the beneficial owner, if any, on whose behalf the proposal is made,
(v)&nbsp;a description of any agreement, arrangement or understanding with respect to the proposal between or among such stockholder
and/or such beneficial owner, any of their respective affiliates or associates, and any others acting in concert with any of the
foregoing, (vi)&nbsp;a description of any agreement, arrangement or understanding (including any derivative or short positions,
profit interests, options, warrants, convertible securities, stock appreciation or similar rights, hedging transactions, and borrowed
or loaned shares) that has been entered into as of the date of the stockholder&rsquo;s notice by, or on behalf of, such stockholder
and such beneficial owner (if any), whether or not such instrument or right shall be subject to settlement in underlying shares
of capital stock of the corporation, the effect or intent of which is to mitigate loss to, manage risk or benefit of share price
changes for, or increase or decrease the voting power of, such stockholder or such beneficial owner, with respect to securities
of the corporation, (vii)&nbsp;a representation that the stockholder is a holder of record of stock of the corporation entitled
to vote at such meeting and intends to appear in person or by proxy at the meeting to propose such business, (viii)&nbsp;a representation
whether the stockholder or the beneficial owner, if any, intends or is part of a group which intends (A)&nbsp;to deliver a proxy
statement and/or form of proxy to holders of at least the percentage of the corporation&rsquo;s outstanding capital stock required
to approve or adopt the proposal and/or (B)&nbsp;otherwise to solicit proxies or votes from stockholders in support of such proposal,
and (ix)&nbsp;any other information relating to such stockholder and beneficial owner, if any, required to be disclosed in a proxy
statement or other filings required to be made in connection with solicitations of proxies for the proposal pursuant to and in
accordance with Section&nbsp;14(a) of the Securities Exchange Act of 1934, as amended (the &ldquo;<U>1934 Act</U>&rdquo;), and
the rules and regulations promulgated thereunder. The foregoing notice requirements of this paragraph (b)&nbsp;shall be deemed
satisfied by a stockholder with respect to business other than a nomination if the stockholder has notified the corporation of
his, her or its intention to present a proposal at an annual meeting in compliance with applicable rules and regulations promulgated
under the 1934 Act and such stockholder&rsquo;s proposal has been included in a proxy statement that has been prepared by the corporation
to solicit proxies for such annual meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(c) Only persons who are nominated in accordance
with the procedures set forth in this paragraph (c)&nbsp;or <U>Section&nbsp;5A</U> shall be eligible for election as directors.
Nominations of persons for election to the Board of Directors of the corporation may be made at an annual meeting or at a special
meeting of stockholders (but only if the election of directors is a matter specified in the notice of meeting given by or at the
direction of the person calling such special meeting) only (A)&nbsp;by or at the direction of the Board of Directors or any committee
thereof, (B)&nbsp;by any stockholder of the corporation who was a stockholder of record of the corporation at the time notice provided
for in this paragraph (c)&nbsp;is delivered to, or mailed and received by, the Secretary of the corporation, who is entitled to
vote at the meeting, and who complies with the notice procedures set forth in this paragraph (c), or (C)&nbsp;with respect to nominations
of persons for election to the Board of Directors of the corporation at an annual meeting of stockholders but not a special meeting
of stockholders, by any stockholder pursuant to <U>Section&nbsp;5A</U>. Any nomination made under clause (B)&nbsp;of this paragraph
(c)&nbsp;shall be made pursuant to timely notice in writing to the Secretary of the corporation in accordance with the provisions
of paragraph (b)&nbsp;of this <U>Section&nbsp;5</U>. A stockholder&rsquo;s notice for purposes of this paragraph (c)&nbsp;shall
set forth (i)&nbsp;as to each person, if any, whom the stockholder proposes to nominate for election or re-election as a director:
(1)&nbsp;the name, age, business address and residence address of such person, (2)&nbsp;the principal occupation or employment
of such person, (3)&nbsp;the class and number of shares of the corporation which are beneficially owned by such person, (4)&nbsp;a
description of all arrangements or understandings between the stockholder giving notice (and the beneficial owner, if any, on whose
behalf such notice is given) and each nominee and any other person or persons (naming such person or persons) pursuant to which
the nominations are to be made by the stockholder and beneficial owner, if any, (4)&nbsp;all other information relating to such
person that is required to be disclosed in solicitations of proxies for election of directors in an election contest, or is otherwise
required, in each case pursuant to and in accordance with Section&nbsp;14(a) of the 1934 Act, (5)&nbsp;such person&rsquo;s written
consent to being named in the proxy statement, if any, as a nominee and to serving as a director of the corporation if elected
and a written statement of such person&rsquo;s intention to serve as a director for the full term for which such person is to stand
for election; and (6)&nbsp;an executed questionnaire pursuant to paragraph (h)&nbsp;of <U>Section&nbsp;5A</U> of these Bylaws,
and (ii)&nbsp;as to such stockholder giving notice and the beneficial owner, if any, on whose behalf such notice is given, the
information required to be provided pursuant to paragraph (b)&nbsp;of this <U>Section 5</U> with respect to a stockholding giving
notice of business thereunder and the beneficial owner, if any, on whose behalf such notice is given. The corporation may require
any proposed nominee to furnish such other information as the corporation may reasonably require to determine the eligibility of
such proposed nominee to serve as a director of the corporation. No person shall be eligible for election as a director of the
corporation unless nominated in accordance with the procedures set forth in this paragraph (c)&nbsp;or in <U>Section&nbsp;5A</U>.
The chairman of the meeting shall, if the facts warrant, determine and declare at the meeting that a nomination was not made in
accordance with the procedures prescribed by these Bylaws, and if he or she should so determine, he or she shall so declare at
the meeting, and the defective nomination shall be disregarded notwithstanding that proxies in respect thereof may have been received
by the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(d) A stockholder providing notice pursuant
to paragraph (b)&nbsp;or (c) above or <U>Section&nbsp;5A</U>, as the case may be, shall further update and supplement such notice,
if necessary, so that the information provided or required to be provided in such notice pursuant to paragraph (b)&nbsp;or (c)
above or <U>Section&nbsp;5A</U>, as applicable, shall be true and correct as of the record date for the meeting and as of the date
that is ten (10)&nbsp;business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement
shall be delivered to, or mailed and received by, the Secretary of the corporation at the principal executive offices of the corporation
not later than five (5)&nbsp;business days after the record date for the meeting (in the case of the update and supplement required
to be made as of the record date), and not later than eight (8)&nbsp;business days prior to the date for the meeting, if practicable
(or, if not practicable, on the first practicable date prior to), or any adjournment or postponement thereof (in the case of the
update and supplement required to be made as of ten (10)&nbsp;business days prior to the meeting or any adjournment or postponement
thereof).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(e) Except as otherwise provided by law,
the chairman of the meeting shall have the power and duty (i)&nbsp;to determine whether any business proposed to be brought before
the meeting pursuant to paragraph (b)&nbsp;above, or any nomination made pursuant to paragraph (c)&nbsp;above or to <U>Section&nbsp;5A</U>,
was proposed or made, as the case may be, in accordance with the procedures set forth in paragraph (b)&nbsp;or paragraph (c)&nbsp;of
Section&nbsp;5 or in <U>Section&nbsp;5A</U>, as the case may be, including whether the stockholder or beneficial owner, if any,
on whose behalf the proposal is brought or nomination is made, as applicable, solicited (or is part of a group which solicited)
or did not so solicit, as the case may be, proxies or votes in support of such stockholder&rsquo;s nominee or proposal in compliance
with such stockholder&rsquo;s representation as required by paragraph (b)&nbsp;or paragraph (c)&nbsp;or <U>Section&nbsp;5A</U>,
as applicable) and (ii)&nbsp;if any proposed business or nomination was not proposed or made in compliance with paragraph (b)&nbsp;or
paragraph (c)&nbsp;or <U>Section&nbsp;5A</U>, as applicable, to declare that such proposed business or nomination shall not be
transacted or made. Notwithstanding the foregoing provisions of this <U>Section&nbsp;5</U> or <U>Section&nbsp;5A</U>, unless otherwise
required by law, if the stockholder (or a qualified representative of the stockholder) does not appear at the annual meeting of
stockholders of the corporation to present any proposed business or nominee, such proposed business shall not be transacted, and
such nomination shall not be made, notwithstanding that proxies in respect thereof may have been received by the corporation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(f) Notwithstanding the foregoing provisions
of this <U>Section&nbsp;5</U>, a stockholder shall also comply with all applicable requirements of the 1934 Act and the rules and
regulations promulgated thereunder with respect to the matters set forth in this <U>Section&nbsp;5</U>; <U>provided</U>, <U>however</U>,
any references in these Bylaws to the 1934 Act or the rules and regulations promulgated thereunder are not intended to and shall
not limit any requirements applicable to nominations or proposals as to any other business to be considered pursuant to this <U>Section&nbsp;5.</U>
Compliance with paragraphs (b)&nbsp;and (c) of this <U>Section&nbsp;5,</U> or with <U>Section&nbsp;5A</U>, as applicable, shall
be the exclusive means for a stockholder to make nominations or submit other business (other than proposals properly made under
and in compliance with Rule 14a-8 of the 1934 Act, as may be amended from time to time). Nothing in this <U>Section&nbsp;5 or in
Section&nbsp;5A</U> shall be deemed to affect any rights (a)&nbsp;of stockholders to request inclusion of proposals or nominations
in the corporation&rsquo;s proxy statement pursuant to applicable rules and regulations promulgated under the 1934 Act or (b)&nbsp;of
the holders of any series of preferred stock of the corporation (&ldquo;<U>Preferred Stock</U>&rdquo;) to elect directors pursuant
to any applicable provisions of the Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(g) For purposes of this <U>Section&nbsp;5</U>
and <U>Section&nbsp;5A</U>, &ldquo;public announcement&rdquo; shall mean disclosure in a press release reported by the Dow Jones
News Service, Associated Press or comparable national news service or in a document publicly filed by the corporation with the
Securities and Exchange Commission pursuant to Section&nbsp;13, 14 or 15(d) of the 1934 Act and the rules and regulations promulgated
thereunder. For purposes of this <U>Section&nbsp;5</U> and <U>Section&nbsp;5A</U>, to be considered a &ldquo;qualified representative&rdquo;
of a stockholder, a person must be a duly authorized officer, manager or partner of such stockholder or must be authorized by a
writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as
proxy at the meeting of stockholders and such person must produce such writing or electronic transmission, or a reliable reproduction
of the writing or electronic transmission, at the meeting of stockholders.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt"><B>SECTION 5A. PROXY ACCESS FOR DIRECTOR NOMINATIONS.
</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) <U>Definitions</U>. For purposes of
this <U>Section&nbsp;5A</U> and as otherwise provided in these Bylaws, the following terms shall have the following meanings:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(i) &ldquo;affiliate&rdquo; shall have
the meaning ascribed thereto under the General Rules&nbsp;and Regulations under the 1934 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(ii) &ldquo;Authorized Group Member&rdquo;
shall mean, with respect to any nomination by a Nominating Group (as defined below), the member of that Nominating Group that is
authorized to act on behalf of all members of that Nominating Group with respect to matters relating to the nomination, including
withdrawal of the nomination.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(iii) &ldquo;Compensation Arrangement&rdquo;
shall mean any direct or indirect compensatory, payment or other financial agreement, arrangement or understanding with any person
or entity other than the corporation, including, without limitation, any agreement, arrangement or understanding with respect to
any direct or indirect compensation, reimbursement or indemnification in connection with candidacy, nomination, service or action
as a nominee or as a director of the corporation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(iv) &ldquo;Eligible Stockholder&rdquo;
shall mean a person who has either (A)&nbsp;been a record holder of shares of common stock of the corporation used to satisfy the
eligibility requirements in paragraph (d)&nbsp;of this <U>Section&nbsp;5A</U> continuously for the required three-year period or
(B) provides to the Secretary of the corporation, within the time period referred to in paragraph (e)&nbsp;of this <U>Section&nbsp;5A,</U>
evidence of continuous Ownership of such shares for such three-year period from one or more securities intermediaries.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(v) &ldquo;Maximum Number&rdquo; shall
mean that number of directors constituting the greater of (A)&nbsp;two or (B) 20% of the number of directors in office of the corporation
on which a Nomination Notice may be submitted pursuant to this <U>Section&nbsp;5A</U> (rounded down to the nearest whole number),
which number shall be reduced as set forth in paragraph (c)(i) of this <U>Section&nbsp;5A</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(vi) &ldquo;Minimum Percentage&rdquo;
shall mean 3% of the number of outstanding shares of common stock of the corporation as provided in the most recent 1934 Act filing
made by the corporation with the SEC immediately prior to the submission of the Nomination Notice.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(vii) &ldquo;Nominating Stockholder&rdquo;
shall mean any Eligible Stockholder or group of no more than 20 stockholders (a &ldquo;<U>Nominating Group</U>&rdquo;) that, individually
and collectively, in the case of a Nominating Group, satisfies the requirements to qualify as an Eligible Stockholder, and that
(A)&nbsp;has (individually and collectively, in the case of a Nominating Group) satisfied all applicable conditions and complied
with all applicable procedures set forth in this <U>Section&nbsp;5A</U> (including, without limitation, the timely submission of
a Nomination Notice that meets the requirements set forth in this <U>Section&nbsp;5A</U>), and (B)&nbsp;has nominated a Stockholder
Nominee.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(viii) &ldquo;Nomination Notice&rdquo;
shall mean all information and documents that a Nominating Stockholder is required to submit to the Secretary of the corporation
pursuant to paragraph (f)&nbsp;of <U>Section&nbsp;5A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(ix) &ldquo;Own&rdquo; shall mean possession,
with respect to those outstanding shares of common stock of the corporation entitled to vote generally for the election of directors
of the corporation, of both: (A)&nbsp;the full voting and investment rights pertaining to such shares; and (B)&nbsp;the full economic
and financial interest in (including the full and complete opportunity for profit and risk of loss on) such shares; <U>provided</U>,
<U>however</U>, that the number of shares calculated in accordance with clauses (A)&nbsp;and (B)&nbsp;shall not include any shares:
(1)&nbsp;sold by such stockholder or any of its affiliates in any transaction that has not been settled or closed, including any
short sale; (2)&nbsp;borrowed by such stockholder or any of its affiliates for any purposes or purchased by such stockholder or
any of its affiliates pursuant to an agreement to resell; or (3)&nbsp;subject to any option, warrant, forward contract, swap, contract
of sale or other derivative or similar agreement entered into by such stockholder or any of its affiliates, whether any such instrument
or agreement is to be settled with shares or with cash based on the notional amount or value of outstanding shares of stock of
the corporation, in any such case which instrument or agreement has, or is intended to have, or if exercised by either party thereto
would have, the purpose or effect of (x)&nbsp;reducing in any manner, to any extent or at any time in the future, such stockholder&rsquo;s
or affiliate&rsquo;s full right to vote or direct the voting of any such shares or (y)&nbsp;hedging, offsetting or altering to
any degree any gain or loss arising from the full economic Ownership of such shares by such stockholder or affiliate, other than
any such arrangements solely involving a national or multi-national multi-industry market index. A stockholder shall &ldquo;Own&rdquo;
shares held in the name of a nominee or other intermediary so long as the stockholder retains the right to instruct how the shares
are voted with respect to the election of directors and the right to direct the disposition thereof and possesses the full economic
interest in the shares. A stockholder&rsquo;s Ownership of shares shall be deemed to continue during any period in which (I)&nbsp;the
stockholder has loaned such shares, provided that the stockholder has the power to recall such loaned shares on five business days&rsquo;
notice or less, or (II)&nbsp;the stockholder has delegated any voting power over such shares by means of a proxy, power of attorney
or other instrument or arrangement which is revocable at any time by the stockholder. The terms&nbsp;&ldquo;Owned,&rdquo; &ldquo;Owning,&rdquo;
&ldquo;Ownership,&rdquo; &ldquo;Owner&rdquo; and other variations of the word &ldquo;Own&rdquo; shall have correlative meanings.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(x) &ldquo;Stock Exchange Rules&rdquo;
shall mean the rules of any stock exchange on which the corporation&rsquo;s securities are traded.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(xi) &ldquo;Stockholder Nominee&rdquo;
shall mean any person nominated for election pursuant to this <U>Section&nbsp;5A</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(xii) &ldquo;Voting Commitment&rdquo;
shall mean any agreement, arrangement or understanding with, and any commitment or assurance to, any person or entity as to how
a person, if elected as a director of the corporation, will act or vote on any issue or question.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) <U>Proxy Access at Annual Meetings</U>.
Subject to the satisfaction of the requirements of this <U>Section&nbsp;5A</U>, if expressly requested in the relevant Nomination
Notice, the corporation shall include in its proxy statement for any annual meeting of stockholders:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(i) the name of any Stockholder Nominee,
which shall also be included on the corporation&rsquo;s form of proxy and ballot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(ii) disclosure about the Stockholder
Nominee and the Nominating Stockholder required under the rules of the SEC or other applicable law, rule or regulation to be included
in the proxy statement; and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(iii) any statement included by the Nominating
Stockholder in the Nomination Notice for inclusion in the proxy statement in support of the Stockholder Nominee&rsquo;s election
to the Board of Directors (subject, without limitation, to paragraph (g)(iii) of this <U>Section&nbsp;5A</U>), but only if such
statement does not exceed 500 words.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the avoidance of doubt, the provisions of this <U>Section&nbsp;5A</U>
shall not apply to a special meeting of stockholders, and the corporation shall not be required to include a director nominee of
a stockholder or group of stockholders under this <U>Section&nbsp;5A</U> in the corporation&rsquo;s proxy statement or form of
proxy or ballot for any special meeting of stockholders.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(c) <U>Maximum Number of Stockholder Nominees</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(i) The corporation shall not be required
to include in the proxy statement for an annual meeting of stockholders more Stockholder Nominees than the Maximum Number. In the
event that one or more vacancies for any reason occurs on the Board of Directors after the deadline set forth in paragraph (e)&nbsp;of
this <U>Section&nbsp;5A</U> but before the date of the annual meeting and the Board of Directors resolves to reduce the size of
the Board of Directors in connection therewith, the Maximum Number shall be calculated based on the number of directors in office
as so reduced. The Maximum Number for a particular annual meeting shall be reduced by:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(A) Stockholder Nominees whose
nominations for election at such annual meeting are subsequently withdrawn;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(B) Stockholder Nominees whom
the Board of Directors itself decides to nominate for election at such annual meeting;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(C) the number of incumbent
directors or director candidates (including, without limitation, candidates who are not Stockholder Nominees) that in either case
will be included in the corporation&rsquo;s proxy materials for an annual meeting of stockholders as unopposed (by the corporation)
nominees pursuant to any agreement, arrangement or other understanding with any stockholder or group of stockholders; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(D) the number of incumbent
directors who were Stockholder Nominees with respect to any of the preceding three annual meetings of stockholders.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(ii) Any Nominating Stockholder submitting
more than one Stockholder Nominee for inclusion in the corporation&rsquo;s proxy materials pursuant to this <U>Section&nbsp;5A</U>
shall rank such Stockholder Nominees based on the order that the Nominating Stockholder desires such Stockholder Nominees to be
selected for inclusion in the corporation&rsquo;s proxy materials. In the event that the number of Stockholder Nominees submitted
by Nominating Stockholders pursuant to this <U>Section&nbsp;5A</U> exceeds the Maximum Number, the highest ranking Stockholder
Nominee who meets the requirements of this <U>Section&nbsp;5A</U> from each Nominating Stockholder will be selected for inclusion
in the corporation&rsquo;s proxy materials until the Maximum Number is reached, going in order of the amount (largest to smallest)
of shares of common stock of the corporation that each Nominating Stockholder disclosed as Owned in its respective Nomination Notice
submitted to the corporation. This selection process will continue with the next highest ranked nominees as many times as necessary,
following the same order each time, until the Maximum Number is reached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(d) <U>Eligible Stockholders</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(i) An Eligible Stockholder or Nominating
Group may submit a nomination in accordance with this <U>Section&nbsp;5A</U> only if the Eligible Stockholder or Nominating Group
(in the aggregate) has continuously Owned at least the Minimum Percentage of shares of common stock of the corporation (as adjusted
for any stock splits, stock dividends, subdivisions, combinations, reclassifications, recapitalizations or similar events) throughout
the three-year period preceding and including the date of submission of the Nomination Notice, and continues to Own at least the
Minimum Percentage of shares of common stock of the corporation through the date of the annual meeting (and any postponement or
adjournment thereof). No shares may be attributed to more than one Eligible Stockholder. The following shall be treated as one
Eligible Stockholder or one member of a Nominating Group if such Eligible Stockholder or member of a Nominating Group shall provide
together with the Nomination Notice documentation that demonstrates compliance with the following criteria: (A)&nbsp;funds under
common management and investment control; (B)&nbsp;funds under common management and funded primarily by the same employer; or
(C)&nbsp;a &ldquo;family of investment companies&rdquo; or a &ldquo;group of investment companies&rdquo; (each as defined in or
under the Investment Company Act of 1940, as amended).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(ii) For the avoidance of doubt, in the
event of a nomination by a Nominating Group, any and all requirements and obligations for a given Eligible Stockholder (including,
without limitation, each and every fund or company that comprises the Nominating Group) that are set forth in this <U>Section&nbsp;5A</U>,
including the minimum holding period, shall apply to each member of such Nominating Group; <U>provided</U>, <U>however</U>, that
the Minimum Percentage of shares of common stock of the corporation shall apply to the Ownership of the Nominating Group in the
aggregate. In the event that any stockholder withdraws from a Nominating Group at any time prior to the annual meeting of stockholders,
the Nominating Group shall only be deemed to Own the shares held by the remaining members of that Nominating Group.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(iii) No stockholder shall be permitted
to be in more than one Nominating Group, and if any stockholder appears as a member of more than one Nominating Group, or as a
member of a Nominating Group and as a Nominating Stockholder without any such group, such stockholder shall be deemed to be a member
of only the Nominating Group that has the largest Ownership position as reflected in the Nomination Notice and is not permitted
to act as a Nominating Stockholder separate from such Nominating Group.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(e) <U>Timely Nomination Notice</U>. To
be timely for purposes of this <U>Section&nbsp;5A</U>, a Nomination Notice must be delivered to the Secretary of the corporation
at the principal executive offices of the corporation not later than the close of business on the 120th day nor earlier than the
close of business on the 150th day prior to the first anniversary of the preceding year&rsquo;s annual meeting except where information
or documents are required to be provided after the date the Nomination Notice is first submitted, as set forth in this <U>Section&nbsp;5A</U>;
<U>provided</U>, <U>however</U>, that in the event that the date of the annual meeting is advanced more than 30&nbsp;days prior
to, or delayed by more than 30&nbsp;days after, the anniversary of the preceding year&rsquo;s annual meeting, the Nomination Notice
to be timely must be so delivered not later than the close of business on the tenth day following the day on which public announcement
(as defined in paragraph (g)&nbsp;of <U>Section&nbsp;5</U> of these Bylaws) of the date of such meeting is first made. In no event
shall the adjournment or postponement of an annual meeting, or the public announcement of such an adjournment or postponement,
commence a new time period (or extend any time period) for the giving of a Nomination Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(f) <U>Nomination Notice</U>. The Nomination
Notice shall consist of, collectively, the following information, documents and agreements which shall, for avoidance of doubt,
be compiled, completed and submitted by the Nominating Stockholder or its representatives at its own cost:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 49.5pt">(i) with respect to the Nominating Stockholder
or, in the case of a Nominating Group, each member of the Nominating Group, documentary evidence in the form of one or more written
statements from the record holder of the shares of common stock of the corporation (and from each intermediary through which the
shares are or have been held during the requisite three-year holding period, provided that each such intermediary must be a participant
in the Depository Trust Company or an affiliate of a participant in the Depository Trust Company) and a representation from the
Nominating Stockholder (or the Authorized Group Member on behalf of each member of a Nominating Group) verifying and certifying
that, as of a date within seven calendar days prior to the date of the Nomination Notice, the Nominating Stockholder (individually
or collectively, in the case of a Nominating Group) Owns, and has continuously Owned for the preceding three years, the Minimum
Percentage of shares, and the Nominating Stockholder&rsquo;s agreement to provide, within five business days after the record date
for the annual meeting, documentary evidence in the form of written statements from each record holder and intermediary and a representation
from the Nominating Stockholder (or the Authorized Group Member on behalf of each member of a Nominating Group) verifying and certifying
the Nominating Stockholder&rsquo;s continuous Ownership (individually or collectively, in the case of a Nominating Group) of the
Minimum Percentage of shares of common stock of the corporation through the record date;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(ii) an undertaking to provide immediate
notice if the Nominating Stockholder ceases to Own the Minimum Percentage of shares of common stock of the corporation prior to
the date of the annual meeting;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(iii) a copy of the Schedule 14N (or any
successor form) relating to the Stockholder Nominee, completed and filed with the SEC by the Nominating Stockholder as applicable,
in accordance with SEC rules;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(iv) the written consent of each Stockholder
Nominee to being named in the corporation&rsquo;s proxy statement, form of proxy and ballot as a nominee and to serving as a director
if elected, and a written statement of each Stockholder Nominee&rsquo;s intention to serve as a director for the full term for
which such person is to stand for election;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(v) a written notice of the nomination
of such Stockholder Nominee that includes the following additional information, agreements, representations and warranties by the
Nominating Stockholder (including, for the avoidance of doubt, each member of a Nominating Group):</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(A) the information and other
deliverables that would be required to be set forth in a stockholder&rsquo;s notice of nomination pursuant to Section&nbsp;5 of
these Bylaws, as if the Nominating Stockholder were the proposing stockholder under that section;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(B) to the extent not included
in the response to paragraph (A)&nbsp;above, a detailed description of all material relationships, between or among the Nominating
Stockholder, on the one hand, and each Stockholder Nominee, on the other hand, including, without limitation, all information that
would be required to be disclosed pursuant to Item 404 of Regulation S-K (or its successor Item) if the Nominating Stockholder
were the &ldquo;registrant&rdquo; for purposes of such item and the Stockholder Nominee was a director or executive officer of
such registrant;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(C) the details of any relationship
that existed within the past three years and that would have been described pursuant to Item 6(e) of Schedule 14N (or any successor
item) if it existed on the date of submission of the Schedule 14N;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(D) a representation and warranty
that the Nominating Stockholder acquired the securities of the corporation in the ordinary course of business and did not acquire,
and is not holding, securities of the corporation with the intent, for the purpose or with the effect of influencing or changing
control of the corporation;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(E) a representation and warranty
that the Nominating Stockholder has not nominated and an agreement that it will not nominate for election to the Board of Directors
at the annual meeting any person other than such Nominating Stockholder&rsquo;s Stockholder Nominee(s);</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(F) a representation and warranty
that the Nominating Stockholder has not engaged in and an agreement that it will not engage in a &ldquo;solicitation&rdquo; within
the meaning of Rule 14a-1(l) under the 1934 Act with respect to the annual meeting, other than with respect to such Nominating
Stockholder&rsquo;s Stockholder Nominee(s) or any nominee of the Board of Directors;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(G) an agreement that the Nominating
Stockholder will not use or distribute any proxy card other than the corporation&rsquo;s proxy card in soliciting stockholders
in connection with the election of a Stockholder Nominee at the annual meeting;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(H) a representation and warranty
that the Stockholder Nominee&rsquo;s candidacy or, if elected, membership on the Board of Directors would not violate applicable
state or federal law or Stock Exchange Rules;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(I) a representation and warranty
that the Stockholder Nominee: (1)&nbsp;qualifies as independent under the Stock Exchange Rules and any publicly disclosed standards
used by the Board of Directors in determining and disclosing the independence of the directors; and (2)&nbsp;is not and has not
been subject to any event specified in Rule 506(d)(1) of Regulation D (or any successor rule) under the Securities Act of 1933,
as amended, or Item 401(f) of Regulation S-K (or any successor rule), without reference to whether the event is material to an
evaluation of the ability or integrity of the Stockholder Nominee;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(J) a representation and warranty
that the Nominating Stockholder satisfies the eligibility requirements set forth in paragraph (d)&nbsp;of this <U>Section&nbsp;5A</U>;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(K) an agreement that the Nominating
Stockholder will continue to satisfy the eligibility requirements described in paragraph (d)&nbsp;of this <U>Section&nbsp;5A</U>
through the date of the annual meeting;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(L) the details of any position
of the Stockholder Nominee as an officer or director of any competitor (i.e., any entity that provides products or services that
compete with or are alternatives to the principal products produced or services provided by the corporation or its affiliates)
of the corporation, within the three years preceding the submission of the Nomination Notice;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(M) if desired by the Nominating
Stockholder and subject to paragraph (g)(ii) of this <U>Section&nbsp;5A</U>, a statement for inclusion in the proxy statement in
support of the Stockholder Nominee&rsquo;s election to the Board of Directors. Any such statement shall not exceed 500 words and
shall fully comply with Section&nbsp;14 of the 1934 Act and the rules and regulations thereunder; and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(N) in the case of a nomination
by a Nominating Group, the designation by all group members of one Authorized Group Member;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(vi) an executed agreement (which form
of agreement shall be provided by the Secretary of the corporation upon written request), which must be submitted within ten days
after the date on which the Secretary of the corporation provides the form of agreement, pursuant to which the Nominating Stockholder
(including each member of a Nominating Group) agrees:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(A) to comply with all applicable
laws, rules and regulations in connection with the nomination, solicitation and election;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(B) to file any written solicitation
or other communication with the corporation&rsquo;s stockholders relating to one or more of the corporation&rsquo;s directors or
director nominees or any Stockholder Nominee with the SEC, regardless of whether any such filing is required under any rule or
regulation or whether any exemption from filing is available for such materials under any rule or regulation;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(C) to assume all liability
stemming from any action, suit or proceeding concerning any actual or alleged legal or regulatory violation arising out of any
communication by the Nominating Stockholder or the Stockholder Nominee nominated by such Nominating Stockholder with the corporation,
its stockholders or any other person, including, without limitation, the Nomination Notice;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(D) to indemnify and hold harmless
(jointly with all other members of a Nominating Group, if applicable) the corporation and each of its directors, officers and employees
individually against any liability, loss, damages, expenses or other costs (including attorneys&rsquo; fees) incurred in connection
with any action, suit or proceeding (whether threatened, pending or completed), whether legal, judicial administrative or investigative,
against the corporation or any of its directors, officers or employees arising out of or relating to a failure or alleged failure
of the Nominating Stockholder or Stockholder Nominee to comply with, or any breach or alleged breach of, its, or his or her, as
applicable, obligations, agreements or representations under or pursuant to this <U>Section&nbsp;5A</U>;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(E) to promptly (and in any
event within 48 hours of discovering such misstatement or omission) notify the corporation if information included in the Nomination
Notice, or in any other communication by the Nominating Stockholder (including with respect to any member of a Nominating Group)
with the corporation, its stockholders or any other person in connection with the nomination or election ceases to be true and
accurate in all material respects (or omits a material fact necessary to make the statements made not misleading), and promptly
notify the corporation of the information that is required to correct the misstatement or omission; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(F) in the event that the Nominating
Stockholder (including any member of a Nominating Group) has failed to continue to satisfy the eligibility requirements described
in paragraph (d)&nbsp;of this <U>Section&nbsp;5A</U>, to promptly notify the corporation; and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(vii) an executed questionnaire, representation
and agreement pursuant to paragraph (h)&nbsp;of this <U>Section&nbsp;5A</U>&nbsp;(which forms of questionnaire, representation
and agreement shall be provided by the Secretary of the corporation promptly upon written request), which must be submitted within
ten days after the date on which the Secretary of the corporation provides the Nominating Stockholder (or the Authorized Group
Member, in the case of a Nominating Group) the forms of questionnaire, representation and agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information and documents required by this paragraph (f)&nbsp;of
<U>Section&nbsp;5A</U> shall be provided with respect to and executed by the Nominating Stockholder (and each member of a Nominating
Group), and provided with respect to the persons specified in Instructions 1 and 2 to Items 6(c) and (d)&nbsp;of Schedule 14N (or
any successor item). The Nomination Notice shall be deemed submitted on the date on which all of the information and documents
referred to in this paragraph (f)&nbsp;of <U>Section&nbsp;5A</U> (other than such information and documents required to be provided
after the date the Nomination Notice is first submitted) have been delivered to or, if sent by mail, received by the Secretary
of the corporation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(g) <U>Exclusion or Disqualification of
Stockholder Nominees</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(i) If, after the deadline for submitting
a Nomination Notice as set forth in paragraph (e)&nbsp;of <U>Section&nbsp;5A</U>, a Nominating Stockholder becomes ineligible or
withdraws its nomination or a Stockholder Nominee becomes ineligible or unwilling to serve on the Board of Directors, whether before
or after the mailing of the corporation&rsquo;s definitive proxy statement, the corporation shall not be required to include in
its proxy statement or on any ballot or form of proxy the Stockholder Nominee or any successor or replacement nominee proposed
by the Nominating Stockholder or by any other Nominating Stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(ii) Notwithstanding anything to the contrary
contained in this <U>Section&nbsp;5A</U>, the corporation may omit from its proxy materials any Stockholder Nominee, and any information
concerning such Stockholder Nominee (including a Nominating Stockholder&rsquo;s statement in support) and communicate to its stockholders
that such Stockholder Nominee will not be eligible for election at the annual meeting or that no vote will be held or occur as
to such Stockholder Nominee, if:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(A) the corporation receives
a notice (whether or not subsequently withdrawn) that a stockholder intends to nominate any candidate for election to the Board
of Directors at the annual meeting pursuant to the advance notice requirements for stockholder nominees set forth in paragraph
(c)&nbsp;of <U>Section&nbsp;5</U> of these Bylaws;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(B) the Nominating Stockholder
has engaged in a &ldquo;solicitation&rdquo; within the meaning of Rule 14a-1(l) under the 1934 Act with respect to the annual meeting,
other than with respect to such Nominating Stockholder&rsquo;s Stockholder Nominee(s) or any nominee of the Board of Directors;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(C) the Nominating Stockholder
or the Authorized Group Member, as applicable, or any qualified representative thereof, does not appear at the annual meeting to
present the nomination submitted in accordance with this <U>Section&nbsp;5A</U>;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(D) the Board of Directors,
acting in good faith, determines that such Stockholder Nominee&rsquo;s nomination or election to the Board of Directors would result
in the corporation violating or failing to be in compliance with these Bylaws or the Certificate of Incorporation, or any applicable
law, rule or regulation to which the corporation is subject, including the Stock Exchange Rules;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(E) the Stockholder Nominee
is not independent under the Stock Exchange Rules&nbsp;and any publicly disclosed standards used by the Board of Directors in determining
and disclosing the independence of the directors, in each case as determined by the Board of Directors;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(F) the Stockholder Nominee
was nominated for election to the Board of Directors pursuant to this <U>Section&nbsp;5A</U> at one of the corporation&rsquo;s
two preceding annual meetings of stockholders and either withdrew from or became ineligible or unavailable for election at such
annual meeting or received a vote of less than 25% of the shares of common stock of the corporation entitled to vote for such Stockholder
Nominee;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(G) the Stockholder Nominee
has been, within the past three years, an officer or director of a competitor, as defined for purposes of Section&nbsp;8 of the
Clayton Antitrust Act of 1914, as amended; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(H) the Nominating Stockholder
has failed to continue to satisfy the eligibility requirements described in paragraph (d)&nbsp;of this <U>Section&nbsp;5A</U>,
any of the representations and warranties made in the Nomination Notice ceases to be true and accurate in all material respects
(or omits a material fact necessary to make the statement made not misleading), the Stockholder Nominee becomes unwilling or unable
to serve on the Board of Directors or any violation or breach occurs of any of the obligations, agreements, representations or
warranties of the Nominating Stockholder or the Stockholder Nominee under or pursuant to this <U>Section&nbsp;5A</U>;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and in such case such nomination shall be disregarded and no
vote on such Stockholder Nominee will occur (notwithstanding that proxies in respect of such vote may have been received by the
corporation), and the Nominating Stockholder may not, after the last day on which a Nomination Notice would be timely, cure in
any way any defect preventing the nomination of the Stockholder Nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(iii) Notwithstanding anything to the
contrary contained in this <U>Section&nbsp;5A</U>, the corporation may omit from its proxy statement, or may supplement or correct,
any information, including all or any portion of the statement in support of the Stockholder Nominee included in the Nomination
Notice, if:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(A) such information is not
true in all material respects or omits a material statement necessary to make the statements made not misleading;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(B) such information directly
or indirectly impugns the character, integrity or personal reputation of, or directly or indirectly makes charges concerning improper,
illegal or immoral conduct or associations, without factual foundation, with respect to, any individual, corporation, partnership,
association or other entity, organization or governmental authority; or</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: 24.5pt">(C) the inclusion of such information
in the proxy statement would otherwise violate the SEC proxy rules or any other applicable law, rule or regulation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt">(iv) The corporation may solicit against,
and include in the proxy statement its own statement in opposition to the nomination of the Stockholder Nominee and any other statement
or information that the corporation or the Board of Directors determines in its discretion to include in the proxy statement relating
to the Stockholder Nominee and/or the Nominating Stockholder, including, without limitation, information relating to any Compensation
Arrangement and/or Voting Commitment, and any of the information provided pursuant to this <U>Section&nbsp;5A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(h) <U>Submission of Questionnaire, Representation
and Agreement</U>. To be eligible to be a nominee for election as a director of the corporation pursuant to <U>Section&nbsp;5</U>
or <U>Section&nbsp;5A</U> of these Bylaws, the person proposed to be nominated must deliver or mail (in accordance with the time
periods prescribed for delivery of notice under <U>Section&nbsp;5</U> or <U>Section&nbsp;5A</U>, as applicable) to the Secretary
of the corporation an executed questionnaire required of the corporation&rsquo;s directors (in the form available from the Secretary
of the corporation) with respect to the background and qualification of such person to serve as a director of the corporation and
the background of any other person or entity on whose behalf the nomination is being made and an executed representation and agreement
(in the form available from the Secretary) that such person: (i)&nbsp;is not and will not become a party to (A)&nbsp;any Voting
Commitment that has not been disclosed to the corporation or (B)&nbsp;any Voting Commitment that could limit or interfere with
such person&rsquo;s ability to comply, if elected as a director of the corporation, with such person&rsquo;s fiduciary duties under
applicable law; (ii)&nbsp;is not and will not become a party to any Compensation Arrangement that has not been disclosed to the
corporation;&nbsp;(iii)&nbsp;if elected as a director of the corporation, will comply with all informational and similar requirements
of applicable insurance policies and laws and regulations in connection with service or action as a director of the corporation;
(iv)&nbsp;if elected as a director of the corporation, will comply with all applicable laws (including, without limitation, fiduciary
duty requirements), policies and guidelines of the corporation, including, without limitation, those relating to stock ownership,
corporate governance, conflict of interest, confidentiality and securities trading; (v)&nbsp;if elected as a director of the corporation,
will act in the best interests of the corporation and its stockholders and not in the interests of individual constituencies; and
(vi)&nbsp;will promptly provide to the corporation such other information as it may reasonably request.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 6. SPECIAL MEETINGS</B>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) Special meetings of the stockholders
of the corporation may be called, for any purpose or purposes, by (i)&nbsp;the Chairman of the Board of Directors, (ii)&nbsp;the
Chief Executive Officer, (iii)&nbsp;the Board of Directors pursuant to a resolution adopted by a majority of the total number of
authorized directors (whether or not there exist any vacancies in previously authorized directorships at the time any such resolution
is presented to the Board of Directors for adoption), or (iv)&nbsp;by the Secretary of the corporation at the request of the holders
of the shares entitled to cast not less than ten percent (10%) of the votes at a meeting of stockholders (assuming all shares entitled
to vote at such meeting were present and voted), and shall be held at such place, if any, on such date, and at such time as the
Board of Directors shall fix.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) If a special meeting is called by any
person or persons other than the Board of Directors, the request shall be in writing, specifying the general nature of the business
proposed to be transacted and the information required in paragraph&nbsp;(b) or (c)&nbsp;of <U>Section&nbsp;5</U> of these Bylaws,
as applicable, and shall be delivered personally or sent by registered mail or by telegraphic or other facsimile transmission to
the Chairman of the Board of Directors, the Chief Executive Officer, or the Secretary of the corporation. The Board of Directors
shall determine the date, time and place, if any, of such special meeting, which shall be held not less than thirty-five (35)&nbsp;nor
more than one hundred twenty (120)&nbsp;days after the date of the receipt of the request. Notwithstanding the foregoing, a special
meeting requested by stockholders shall not be held if the Board of Directors has called or calls for an annual meeting of stockholders
to be held within ninety (90)&nbsp;days after the Secretary of the corporation receives the request for the special meeting and
the Board of Directors determines in good faith that the business of such annual meeting includes (among any other matters properly
brought before the annual meeting) any identical or substantially similar item of business as specified in the special meeting
request. For purposes of this paragraph (b)&nbsp;of <U>Section&nbsp;6</U>, the election or removal of directors shall be deemed
a &ldquo;similar item&rdquo; with respect to all items of business involving the election or removal of directors, changing the
size of the Board of Directors and the filling of vacancies and/or newly created directorships resulting from any increase in the
authorized number of directors. A stockholder may revoke a request for a special meeting at any time by written revocation delivered
to the Secretary of the corporation, and if, following such revocation, there are un-revoked requests from stockholders holding
in the aggregate less than the requisite number of shares entitling the stockholders to request the calling of a special meeting,
the Board of Directors, in its discretion, may cancel the special meeting.&nbsp;Upon determination of the date, time and place
(if any) of the meeting, the officer receiving the request shall cause notice to be given to the stockholders entitled to vote,
in accordance with the provisions of <U>Section&nbsp;7</U> of these Bylaws. Only such business shall be conducted at a special
meeting of stockholders as shall have been brought before the meeting pursuant to the corporation&rsquo;s notice of meeting.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(c) In the event the corporation calls
a special meeting of stockholders for the purpose of electing one or more directors to the Board of Directors, any stockholder
entitled to vote in such election of directors may nominate a person or persons (as the case may be) for election to such position(s)
as specified in the corporation&rsquo;s notice of meeting if the stockholder delivers notice of such nomination to the Secretary
at the principal executive offices of the corporation not earlier than the close of business on the ninetieth (90th) day prior
to such special meeting and not later than the close of business on the later of the sixtieth (60th) day prior to such special
meeting or, in the event public announcement of the date of such special meeting is first made by the corporation fewer than seventy
(70)&nbsp;days prior to the date of such special meeting, the close of business on the tenth (10th) day following the day on which
public announcement of the date of such meeting is first made by the corporation. In no event shall the public announcement of
an adjournment or postponement of a special meeting commence a new time period (or extend any time period) for the giving of a
stockholder&rsquo;s notice as described above. Such notice shall contain all such information required to be included, and such
otherwise comply with, a stockholder&rsquo;s notice of nomination delivered pursuant to paragraph (c)&nbsp;of <U>Section&nbsp;5</U>.
For the avoidance of doubt, stockholders are not permitted to nominate persons for election to the Board of Directors pursuant
to <U>Section&nbsp;5A</U> at a special meeting of stockholders.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(d) Nothing contained in this <U>Section&nbsp;6</U>
shall be construed as limiting, fixing, or affecting the time when a meeting of stockholders called by action of the Board of Directors
may be held.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 7. NOTICE OF MEETINGS</B>. Except
as otherwise provided by law, the Certificate of Incorporation or these Bylaws, written notice of each meeting of stockholders
shall be given not less than ten (10)&nbsp;nor more than sixty (60)&nbsp;days before the date of the meeting to each stockholder
entitled to vote at such meeting, such notice to specify the place, if any, date and hour of the meeting, the means of remote communications,
if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting, the record date
for determining the stockholders entitled to vote at the meeting (if such date is different from the record date for determining
stockholders entitled to notice of the meeting), and, in the case of a special meeting, the purpose or purposes for which the meeting
is called. Any previously scheduled meeting of stockholders may be postponed and any special meeting of stockholders may be canceled,
by resolution of the Board upon public notice given prior to the date previously scheduled for such meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B></B></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 8. QUORUM</B>. At all meetings
of stockholders, except where otherwise provided by statute, the Certificate of Incorporation or these Bylaws, the presence, in
person or by proxy duly authorized, of the holders of a majority of the outstanding shares of stock entitled to vote shall constitute
a quorum for the transaction of business. In the absence of a quorum, any meeting of stockholders may be adjourned, from time to
time, either by the chairman of the meeting or by vote of the holders of a majority of the shares represented thereat, but no other
business shall be transacted at such meeting. The stockholders present at a duly called or convened meeting, at which a quorum
is present, may continue to transact business until adjournment, notwithstanding the withdrawal of enough stockholders to leave
less than a quorum. Where a separate vote by a class or classes or series is required, except where otherwise provided by statute,
the Certificate of Incorporation or these Bylaws, a majority of the outstanding shares of such class or classes or series, present
in person or represented by proxy, shall constitute a quorum entitled to take action with respect to that vote on that matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 9. ADJOURNMENT AND NOTICE OF
ADJOURNED MEETINGS</B>. Any meeting of stockholders, whether annual or special, may be adjourned from time to time, whether or
not a quorum is present, either by the chairman of the meeting (for any or no reason) or by the vote of a majority of the shares
casting votes, excluding abstentions. When a meeting is adjourned to another time or place, notice need not be given of the adjourned
meeting if the time and place, if any, thereof, and the means of remote communications, if any, by which stockholders and proxy
holders may be deemed to be present in person and vote at such adjourned meeting, are announced at the meeting at which the adjournment
is taken. At the adjourned meeting, the corporation may transact any business which might have been transacted at the original
meeting. If the adjournment is for more than thirty (30)&nbsp;days or if after the adjournment a new record date for determination
of stockholders entitled to vote at the meeting is fixed for the adjourned meeting, the Board of Directors shall fix as the record
date for determining stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination
of stockholders entitled to vote at the adjourned meeting, and shall give notice of the adjourned meeting to each stockholder of
record as of the record date so fixed for notice of such adjourned meeting.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 10. VOTING RIGHTS</B>. For the
purpose of determining those stockholders entitled to vote at any meeting of the stockholders, except as otherwise provided by
law, only persons in whose names shares stand on the stock records of the corporation on the record date for determining stockholders
entitled to vote, as determined in accordance with <U>Section&nbsp;37</U> of these Bylaws, shall be entitled to vote at any meeting
of stockholders. Every person entitled to vote shall have the right to do so either in person or by a proxy granted in accordance
with Delaware law. No proxy shall be voted after three (3)&nbsp;years from its date of creation unless the proxy provides for a
longer period. Except as otherwise provided by law, the Certificate of Incorporation or these Bylaws, any question or matter submitted
to a vote of stockholders shall be approved by the holders of a majority of the votes cast thereon; <U>provided</U>, <U>however</U>,
directors shall be elected by a plurality of the votes cast if, as of the date of the meeting of the stockholders, the number of
nominees exceeds the number of directors to be elected. In relation to the election of a director at a meeting where the number
of nominees does not exceed the number of directors to be elected, a majority of votes cast shall mean that the number of shares
voted &ldquo;for&rdquo; a director&rsquo;s election exceeds fifty percent (50%) of the number of votes cast with respect to that
director&rsquo;s election, with votes cast including votes to withhold authority in each case and excluding abstentions with respect
to that director&rsquo;s election. Notwithstanding anything to the contrary set forth in these Bylaws, (x)&nbsp;the non-binding
advisory vote with respect to executive compensation pursuant to Section&nbsp;14A(a)(1) of the 1934 Act, and the rules and regulations
promulgated thereunder, shall require the affirmative vote of a majority of the votes cast thereon, and (y)&nbsp;the non-binding
advisory vote, pursuant to Section&nbsp;14A(a)(2) of the 1934 Act, and the rules and regulations promulgated thereunder, with respect
to the determination as to whether the vote described in the preceding clause (x)&nbsp;shall occur every one (1), two (2)&nbsp;or
three (3)&nbsp;years shall be decided by a plurality of the votes cast. For purposes of this <U>Section&nbsp;10</U>, neither abstentions
nor broker non-votes shall count as votes cast.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 11. JOINT OWNERS OF STOCK</B>.
If shares or other securities having voting power stand of record in the names of two (2)&nbsp;or more persons, whether fiduciaries,
members of a partnership, joint tenants, tenants in common, tenants by the entirety, or otherwise, or if two (2)&nbsp;or more persons
have the same fiduciary relationship respecting the same shares, unless the Secretary is given written notice to the contrary and
is furnished with a copy of the instrument or order appointing them or creating the relationship wherein it is so provided, their
acts with respect to voting shall have the following effect: (a)&nbsp;if only one (1)&nbsp;votes, its, his or her act binds all;
(b)&nbsp;if more than one (1)&nbsp;votes, the act of the majority so voting binds all; (c)&nbsp;if more than one (1)&nbsp;votes,
but the vote is evenly split on any particular matter, each faction may vote the securities in question proportionally, or may
apply to the Delaware Court of Chancery for relief as provided in the General Corporation Law of the State of Delaware (the &ldquo;<U>General
Corporation Law</U>&rdquo;), Section&nbsp;217(b). If the instrument filed with the Secretary shows that any such tenancy is held
in unequal interests, a majority or even-split for the purpose of subsection (c)&nbsp;shall be a majority or even-split in interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B></B></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 12. LIST OF STOCKHOLDERS</B>.
The Secretary shall prepare and make, at least ten (10)&nbsp;days before every meeting of stockholders, a complete list of the
stockholders entitled to vote at said meeting (<U>provided</U>, <U>however</U>, if the record date for determining the stockholders
entitled to vote is less than ten (10)&nbsp;days before the date of the meeting, the list shall reflect the stockholders entitled
to vote as of the tenth (10th) day before the meeting date), arranged in alphabetical order, showing the address of each stockholder
and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder,
for any purpose germane to the meeting, at least ten (10)&nbsp;days prior to the meeting (i)&nbsp;on a reasonably accessible electronic
network, provided that the information required to gain access to such list is provided with the notice of meeting, or (ii)&nbsp;during
ordinary business hours at the principal place of business of the corporation. If the meeting is to be held at a place, then a
list of stockholders entitled to vote at the meeting shall be produced and kept at the time and place of the meeting during the
whole time thereof and may be examined by any stockholder who is present. If the meeting is to be held solely by means of remote
communication, then the list shall also be open to the examination of any stockholder during the whole time of the meeting on a
reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of
the meeting. Except as otherwise provided by law, the stock ledger shall be the only evidence as to who are the stockholders entitled
to examine the list of stockholders required by this <U>Section&nbsp;12</U> or to vote in person or by proxy at any meeting of
stockholders.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 13. ACTION WITHOUT MEETING</B>.
Unless otherwise provided in the Certificate of Incorporation, no action shall be taken by the stockholders except at an annual
or special meeting of stockholders called in accordance with these Bylaws, and no action shall be taken by the stockholders by
written consent.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 14. ORGANIZATION</B>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) At every meeting of stockholders, the
Chairman of the Board of Directors, or, if a Chairman has not been appointed or is absent, the President, or, if the President
is absent, a chairman of the meeting chosen by a majority in interest of the stockholders entitled to vote, present in person or
by proxy, shall act as chairman. The Secretary, or, in his or her absence, an Assistant Secretary directed to do so by the President,
shall act as secretary of the meeting.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) The Board of Directors of the corporation
shall be entitled to make such rules or regulations for the conduct of meetings of stockholders as it shall deem necessary, appropriate
or convenient. Subject to such rules and regulations of the Board of Directors, if any, the chairman of the meeting shall have
the right and authority to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such
chairman, are necessary, appropriate or convenient for the proper conduct of the meeting, including, without limitation, establishing
an agenda or order of business for the meeting, rules and procedures for maintaining order at the meeting and the safety of those
present, limitations on attendance at or participation in such meeting to stockholders of record of the corporation and their duly
authorized and constituted proxies and such other persons as the chairman shall permit, restrictions on entry to the meeting after
the time fixed for the commencement thereof, limitations on the time allotted to questions or comments by participants, regulation
of the opening and closing of the polls for balloting on matters which are to be voted on by ballot, removal of any stockholder
or individual who refuses to comply with meeting procedures, rules or guidelines, and restrictions on the use of audio/video recording
devices, cell phones and other electronic devices. Unless and to the extent determined by the Board of Directors or the chairman
of the meeting, meetings of stockholders shall not be required to be held in accordance with rules of parliamentary procedure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE IV </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DIRECTORS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 15. NUMBER AND TERM OF OFFICE</B>.
The authorized number of directors of the corporation shall be fixed in accordance with the Certificate of Incorporation. Directors
need not be stockholders unless so required by the Certificate of Incorporation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 16. POWERS</B>. The business
and affairs of the corporation shall be managed by or under the direction of the Board of Directors.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 17. CLASSES OF DIRECTORS</B>.
Subject to the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances,
the directors shall be divided into three classes as provided in the Company&rsquo;s Certificate of Incorporation, as amended from
time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B></B></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 18. VACANCIES</B>. Unless otherwise
provided in the Certificate of Incorporation, any vacancies on the Board of Directors resulting from death, resignation, disqualification,
removal or other causes, and any newly created directorships resulting from any increase in the number of directors shall, unless
the Board of Directors determines by resolution that any such vacancies or newly created directorships shall be filled by stockholders,
be filled only by the affirmative vote of a majority of the directors then in office, even though less than a quorum of the Board
of Directors. Any director elected in accordance with the preceding sentence shall hold office for the remainder of the full term
of the director for which the vacancy was created or occurred and until such director&rsquo;s successor shall have been elected
and qualified.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 19. RESIGNATION</B>. Any director
may resign at any time by delivering his or her written resignation to the Secretary, such resignation to specify whether it will
be effective at a particular time, upon receipt by the Secretary or at the pleasure of the Board of Directors. If no such specification
is made, it shall be deemed effective when delivered. When one or more directors shall resign from the Board of Directors, effective
at a future date, a majority of the directors then in office, including those who have so resigned, shall have power to fill such
vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective, and each director
so chosen shall hold office for the unexpired portion of the term of the director whose place shall be vacated and until his or
her successor shall have been duly elected and qualified.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 20. REMOVAL</B>. Subject to
the rights of the holders of any series of Preferred Stock, no director shall be removed without cause. Subject to any limitations
imposed by law, the Board of Directors or any individual director may be removed from office at any time with cause by the affirmative
vote of the holders of a majority of the voting power of all the then-outstanding shares of voting stock of the corporation, entitled
to vote at an election of directors (the &ldquo;<U>Voting Stock</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 21. MEETINGS</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) <U>ANNUAL MEETINGS</U>. The annual
meeting of the Board of Directors shall be held immediately before or after the annual meeting of stockholders. No notice of an
annual meeting of the Board of Directors shall be necessary and such meeting shall be held for the purpose of electing officers
and transacting such other business as may lawfully come before it.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) <U>REGULAR MEETINGS</U>. Except as
hereinafter otherwise provided, regular meetings of the Board of Directors shall be held in the office of the corporation required
to be maintained pursuant to <U>Section&nbsp;2</U> hereof. Unless otherwise restricted by the Certificate of Incorporation, regular
meetings of the Board of Directors may also be held at any place within or without the State of Delaware which has been designated
by resolution of the Board of Directors or the written consent of all directors.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(c) <U>SPECIAL MEETINGS</U>. Unless otherwise
restricted by the Certificate of Incorporation, special meetings of the Board of Directors may be held at any time and place within
or without the State of Delaware whenever called by the Chairman of the Board, the President or any two of the directors.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(d) <U>TELEPHONE MEETINGS</U>. Any member
of the Board of Directors, or of any committee thereof, may participate in a meeting by means of conference telephone or similar
communications equipment by means of which all persons participating in the meeting can hear each other, and participation in a
meeting by such means shall constitute presence in person at such meeting.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(e) <U>NOTICE OF MEETINGS</U>. Notice of
the time and place of all special meetings of the Board of Directors shall be given orally or in writing, by telephone, including
a voice messaging system or other system or technology designed to record and communicate messages, facsimile, telegraph or telex,
or by electronic mail or other electronic means, during normal business hours, at least twenty-four (24)&nbsp;hours before the
date and time of the meeting, or sent in writing to each director by first class mail, charges prepaid, at least three (3)&nbsp;days
before the date of the meeting.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 22. QUORUM AND VOTING</B>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) Unless the Certificate of Incorporation
requires a greater number and except with respect to indemnification questions arising under <U>Section&nbsp;43</U> hereof, for
which a quorum shall be one-third of the exact number of directors fixed from time to time in accordance with the Certificate of
Incorporation, a quorum of the Board of Directors shall consist of a majority of the exact number of directors fixed from time
to time by the Board of Directors in accordance with the Certificate of Incorporation; <U>provided</U>, <U>however</U>, at any
meeting whether a quorum be present or otherwise, a majority of the directors present may adjourn from time to time until the time
fixed for the next regular meeting of the Board of Directors, without notice other than by announcement at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) At each meeting of the Board of Directors
at which a quorum is present, all questions and business shall be determined by the affirmative vote of a majority of the directors
present, unless a different vote be required by law, the Certificate of Incorporation or these Bylaws.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 23. ACTION WITHOUT MEETING</B>.
Unless otherwise restricted by the Certificate of Incorporation or these Bylaws, any action required or permitted to be taken at
any meeting of the Board of Directors or of any committee thereof may be taken without a meeting, if all members of the Board of
Directors or committee, as the case may be, consent thereto in writing or by electronic transmission (including, for the avoidance
of doubt, email consent without a signature), and such writing or writings (or electronic transmission(s)) are filed with the minutes
of proceedings of the Board of Directors or committee.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 24. FEES AND COMPENSATION</B>.
Directors shall be entitled to such compensation for their services as may be approved by the Board of Directors, including, if
so approved, by resolution of the Board of Directors, a fixed sum and expenses of attendance, if any, for attendance at each regular
or special meeting of the Board of Directors and at any meeting of a committee of the Board of Directors. Nothing herein contained
shall be construed to preclude any director from serving the corporation in any other capacity as an officer, agent, employee,
or otherwise and receiving compensation therefor.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 25. COMMITTEES</B>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt">(a) <U>EXECUTIVE COMMITTEE</U>. The Board
of Directors may appoint an Executive Committee to consist of one (1)&nbsp;or more members of the Board of Directors. The Executive
Committee, to the extent permitted by law and provided in the resolution of the Board of Directors, shall have and may exercise
all the powers and authority of the Board of Directors in the management of the business and affairs of the corporation, and may
authorize the seal of the corporation to be affixed to all papers which may require it; but no such committee shall have the power
or authority in reference to (i)&nbsp;approving or adopting, or recommending to the stockholders, any action or matter expressly
required by the General Corporation Law to be submitted to stockholders for approval, or (ii)&nbsp;adopting, amending or repealing
any bylaw of the corporation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) <U>OTHER COMMITTEES</U>. The Board
of Directors may, from time to time, appoint such other committees as may be permitted by law. Such other committees appointed
by the Board of Directors shall consist of one (1)&nbsp;or more members of the Board of Directors and shall have such powers and
perform such duties as may be prescribed by the resolution or resolutions creating such committees, but in no event shall any such
committee have the powers denied to the Executive Committee in these Bylaws.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(c) <U>TERM</U>. Each member of a committee
of the Board of Directors shall serve a term on the committee coexistent with such member&rsquo;s term on the Board of Directors.
The Board of Directors, subject to the provisions of subsections (a)&nbsp;or (b) of this <U>Section&nbsp;25</U> may at any time
increase or decrease the number of members of a committee or terminate the existence of a committee. The membership of a committee
member shall terminate on the date of his or her death, voluntary resignation from the committee or from the Board of Directors,
removal from such committee or the Board of Directors, or disqualification as a director or member of the committee. The Board
of Directors may at any time for any reason remove any individual committee member and the Board of Directors may fill any committee
vacancy created by death, resignation, removal, disqualification or increase in the number of members of the committee. The Board
of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified
member at any meeting of the committee, and, in the absence or disqualification of any member of a committee, the member or members
thereof present at any meeting and not disqualified from voting, whether or not he, she or they constitute a quorum, may unanimously
appoint another member of the Board of Directors to act at the meeting in the place of any such absent or disqualified member.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(d) <U>MEETINGS</U>. Unless the Board of
Directors shall otherwise provide, regular meetings of the Executive Committee or any other committee appointed pursuant to this
<U>Section&nbsp;25</U> shall be held at such times and places as are determined by the Board of Directors, or by any such committee,
and when notice thereof has been given to each member of such committee, no further notice of such regular meetings need be given
thereafter. Special meetings of any such committee may be held at any place which has been determined from time to time by such
committee, and may be called by any director who is a member of such committee, upon written notice to the members of such committee
of the time and place of such special meeting given in the manner provided for the giving of written notice to members of the Board
of Directors of the time and place of special meetings of the Board of Directors. A majority of the authorized number of members
of any such committee shall constitute a quorum for the transaction of business, and the act of a majority of those present at
any meeting at which a quorum is present shall be the act of such committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B></B></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 26. ORGANIZATION; CHAIRMAN OF
THE BOARD OF DIRECTORS</B>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) At every meeting of the directors,
the Chairman of the Board of Directors, or, if a Chairman has not been appointed or is absent, the President, or if the President
is absent, the most senior Vice President, or, in the absence of any such officer, a chairman of the meeting chosen by a majority
of the directors present, shall preside over the meeting. The Secretary, or in his or her absence, an Assistant Secretary directed
to do so by the President, shall act as secretary of the meeting.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) The Chairman of the Board of Directors,
when present, or another person designated by the Chairman of the Board of Directors, shall preside at all meetings of the stockholders.
The Chairman of the Board of Directors shall perform other duties commonly incident to his or her office and shall also perform
such other duties and have such other powers as the Board of Directors shall designate from time to time. If there is no President,
then the Chairman of the Board of Directors shall also serve as the Chief Executive Officer of the corporation and shall have the
powers and duties prescribed in paragraph (b)&nbsp;of <U>Section&nbsp;28</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE V </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OFFICERS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 27. OFFICERS DESIGNATED</B>.
The officers of the corporation shall include, if and when designated by the Board of Directors, the Chief Executive Officer, the
President, one or more Vice Presidents, the Secretary, the Chief Financial Officer, the Treasurer and the Controller, all of whom
shall be elected at the annual organizational meeting of the Board of Directors. The Board of Directors may also appoint one or
more Assistant Secretaries, Assistant Treasurers, Assistant Controllers and such other officers and agents with such powers and
duties as it shall deem necessary. The Board of Directors may assign such additional titles to one or more of the officers as it
shall deem appropriate. Any one person may hold any number of offices of the corporation at any one time unless specifically prohibited
therefrom by law. The salaries and other compensation of the officers of the corporation shall be fixed by or in the manner designated
by the Board of Directors.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 28. TENURE AND DUTIES OF OFFICERS</B>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) <U>GENERAL</U>. All officers shall
hold office at the pleasure of the Board of Directors and until their successors shall have been duly elected and qualified, unless
sooner removed. Any officer elected or appointed by the Board of Directors may be removed at any time by the Board of Directors.
If the office of any officer becomes vacant for any reason, the vacancy may be filled by the Board of Directors.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) <U>DUTIES OF PRESIDENT</U>. The President
shall preside at all meetings of the stockholders and at all meetings of the Board of Directors, unless the Chairman of the Board
of Directors has been appointed and is present. Unless some other officer has been elected Chief Executive Officer of the corporation,
the President shall be the chief executive officer of the corporation and shall, subject to the control of the Board of Directors,
have general supervision, direction and control of the business and officers of the corporation. The President shall perform other
duties commonly incident to his or her office and shall also perform such other duties and have such other powers as the Board
of Directors shall designate from time to time.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(c) <U>DUTIES OF VICE PRESIDENTS</U>. The
Vice Presidents may assume and perform the duties of the President in the absence or disability of the President or whenever the
office of President is vacant. The Vice Presidents shall perform other duties commonly incident to their office and shall also
perform such other duties and have such other powers as the Board of Directors or the President shall designate from time to time.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(d) <U>DUTIES OF SECRETARY</U>. The Secretary
shall attend all meetings of the stockholders and of the Board of Directors and shall record all acts and proceedings thereof in
the minute book of the corporation. The Secretary shall give notice in conformity with these Bylaws of all meetings of the stockholders
and of all meetings of the Board of Directors and any committee thereof requiring notice. The Secretary shall perform all other
duties given him or her in these Bylaws and other duties commonly incident to his or her office and shall also perform such other
duties and have such other powers as the Board of Directors shall designate from time to time. The President may direct any Assistant
Secretary to assume and perform the duties of the Secretary in the absence or disability of the Secretary, and each Assistant Secretary
shall perform other duties commonly incident to his or her office and shall also perform such other duties and have such other
powers as the Board of Directors or the President shall designate from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(e) <U>DUTIES OF CHIEF FINANCIAL OFFICER</U>.
The Chief Financial Officer shall keep or cause to be kept the books of account of the corporation in a thorough and proper manner
and shall render statements of the financial affairs of the corporation in such form and as often as required by the Board of Directors
or the President. The Chief Financial Officer, subject to the order of the Board of Directors, shall have the custody of all funds
and securities of the corporation. The Chief Financial Officer shall perform other duties commonly incident to his or her office
and shall also perform such other duties and have such other powers as the Board of Directors or the President shall designate
from time to time. The President may direct the Treasurer or any Assistant Treasurer, or the Controller or any Assistant Controller
to assume and perform the duties of the Chief Financial Officer in the absence or disability of the Chief Financial Officer, and
each Treasurer and Assistant Treasurer and each Controller and Assistant Controller shall perform other duties commonly incident
to his or her office and shall also perform such other duties and have such other powers as the Board of Directors or the President
shall designate from time to time.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 29. DELEGATION OF AUTHORITY</B>.
The Board of Directors may from time to time delegate the powers or duties of any officer to any other officer or agent, notwithstanding
any provision hereof.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 30. RESIGNATIONS</B>. Any officer
may resign at any time by giving written notice to the Board of Directors or to the President or to the Secretary. Any such resignation
shall be effective when received by the person or persons to whom such notice is given, unless a later time is specified therein,
in which event the resignation shall become effective at such later time. Unless otherwise specified in such notice, the acceptance
of any such resignation shall not be necessary to make it effective. Any resignation shall be without prejudice to the rights,
if any, of the corporation under any contract with the resigning officer.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 31. REMOVAL</B>. Any officer
may be removed from office at any time, either with or without cause, by the affirmative vote of a majority of the directors in
office at the time, or by the unanimous written consent of the directors in office at the time, or by any committee or superior
officers upon whom such power of removal may have been conferred by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE VI </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXECUTION OF CORPORATE INSTRUMENTS AND
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTING OF SECURITIES OWNED BY THE CORPORATION
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 32. EXECUTION OF CORPORATE INSTRUMENTS</B>.
The Board of Directors may, in its discretion, determine the method and designate the signatory officer or officers, or other person
or persons, to execute on behalf of the corporation any corporate instrument or document, or to sign on behalf of the corporation
the corporate name without limitation, or to enter into contracts on behalf of the corporation, except where otherwise provided
by law, the Certificate of Incorporation or these Bylaws, and such execution or signature shall be binding upon the corporation.
Unless otherwise specifically determined by the Board of Directors or otherwise required by law, promissory notes, deeds of trust,
mortgages and other evidences of indebtedness of the corporation, and other corporate instruments or documents requiring the corporate
seal, and certificates of shares of stock owned by the corporation, shall be executed, signed or endorsed by the Chairman of the
Board of Directors, or the President or any Vice President, and by the Secretary or Treasurer or any Assistant Secretary or Assistant
Treasurer. All other instruments and documents requiring the corporate signature, but not requiring the corporate seal, may be
executed as aforesaid or in such other manner as may be directed by the Board of Directors. All checks and drafts drawn on banks
or other depositaries on funds to the credit of the corporation or in special accounts of the corporation shall be signed by such
person or persons as the Board of Directors shall authorize so to do. Unless authorized or ratified by the Board of Directors or
within the agency power of an officer, no officer, agent or employee shall have any power or authority to bind the corporation
by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 33. VOTING OF SECURITIES OWNED
BY THE CORPORATION</B>. All stock and other securities of other corporations or entities owned or held by the corporation for itself,
or for other parties in any capacity, shall be voted, and all proxies with respect thereto shall be executed, by the person authorized
so to do by resolution of the Board of Directors, or, in the absence of such authorization, by the Chairman of the Board of Directors,
the Chief Executive Officer, the President, or any Vice President.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE VII </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SHARES OF STOCK </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 34. FORM AND EXECUTION OF CERTIFICATES</B>.
Shares of the capital stock of the corporation shall be represented by certificates; <U>provided</U>, <U>however</U>, the Board
of Directors may provide by resolution that some or all of any or all classes or series of its stock shall be uncertificated shares.
Every holder of stock represented by certificates shall be entitled to have a certificate signed by or in the name of the corporation
by the Chairman of the Board of Directors, or the President or any Vice President, and by the Treasurer or Assistant Treasurer
or the Secretary or Assistant Secretary, certifying the number of shares owned by such holder in the corporation. Certificates
for the shares of stock of the corporation shall be in such form as is consistent with the Certificate of Incorporation and applicable
law. Any or all of the signatures on the certificates may be facsimiles. In case any officer, transfer agent, or registrar who
has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent,
or registrar before such certificate is issued, it may be issued with the same effect as if he or she were such officer, transfer
agent, or registrar at the date of issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 35. LOST CERTIFICATES</B>. A
new certificate or certificates or uncertificated shares may be issued in place of any certificate or certificates theretofore
issued by the corporation alleged to have been lost, stolen, or destroyed, upon the making of an affidavit of that fact by the
person claiming the certificate of stock to be lost, stolen, or destroyed. The corporation may require, as a condition precedent
to the issuance of a new certificate or certificates or uncertificated shares, the owner of such lost, stolen, or destroyed certificate
or certificates, or its, his or her legal representative, to advertise the same in such manner as it shall require or to give the
corporation a surety bond in such form and amount as it may direct as indemnity against any claim that may be made against the
corporation with respect to the certificate alleged to have been lost, stolen, or destroyed.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 36. TRANSFERS</B>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) Transfers of record of shares of stock
of the corporation shall be made only upon its books by the holders thereof, in person or by attorney duly authorized, and upon
the surrender of a properly endorsed certificate or certificates for a like number of shares (or, in the case of uncertificated
shares, in accordance with applicable law).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) The corporation shall have power to
enter into and perform any agreement with any number of stockholders of any one or more classes of stock of the corporation to
restrict the transfer of shares of stock of the corporation of any one or more classes owned by such stockholders in any manner
not prohibited by the General Corporation Law.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 37. FIXING RECORD DATES</B>.
In order that the corporation may determine the stockholders entitled to notice of any meeting of stockholders or any adjournment
thereof, the Board of Directors may fix, in advance, a record date, which record date shall not precede the date upon which the
resolution fixing the record date is adopted by the Board of Directors, and which record date shall not be more than sixty (60)&nbsp;nor
less than ten (10)&nbsp;days before the date of such meeting. If the Board of Directors so fixes a date, such date shall also be
the record date for determining the stockholders entitled to vote at such meeting unless the Board of Directors determines, at
the time it fixes such record date, that a later date on or before the date of the meeting shall be the date for making such determination.
If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to
vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given,
or if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination
of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting;
<U>provided</U>, <U>however</U>, the Board of Directors may fix a new record date for the determination of stockholders entitled
to vote at the adjourned meeting, and in such case shall also fix as the record date for stockholders entitled to notice of such
adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance herewith
at the adjourned meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 38. REGISTERED STOCKHOLDERS</B>.
The corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to
receive dividends, and to vote as such owner, and shall not be bound to recognize any equitable or other claim to or interest in
such share or shares on the part of any other person whether or not it shall have express or other notice thereof, except as otherwise
provided by the laws of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE VIII </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OTHER SECURITIES OF THE CORPORATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 39. EXECUTION OF OTHER SECURITIES</B>.
All bonds, debentures and other corporate securities of the corporation, other than stock certificates (covered in <U>Section&nbsp;34</U>),
may be signed by the Chairman of the Board of Directors, the President or any Vice President, or such other person as may be authorized
by the Board of Directors, and the corporate seal impressed thereon or a facsimile of such seal imprinted thereon and attested
by the signature of the Secretary or an Assistant Secretary, or the Chief Financial Officer or Treasurer or an Assistant Treasurer;
<U>provided</U>, <U>however</U>, where any such bond, debenture or other corporate security shall be authenticated by the manual
signature, or where permissible facsimile signature, of a trustee under an indenture pursuant to which such bond, debenture or
other corporate security shall be issued, the signatures of the persons signing and attesting the corporate seal on such bond,
debenture or other corporate security may be the imprinted facsimile of the signatures of such persons. Interest coupons appertaining
to any such bond, debenture or other corporate security, authenticated by a trustee as aforesaid, shall be signed by the Treasurer
or an Assistant Treasurer of the corporation or such other person as may be authorized by the Board of Directors, or bear imprinted
thereon the facsimile signature of such person. In case any officer who shall have signed or attested any bond, debenture or other
corporate security, or whose facsimile signature shall appear thereon or on any such interest coupon, shall have ceased to be such
officer before the bond, debenture or other corporate security so signed or attested shall have been delivered, such bond, debenture
or other corporate security nevertheless may be adopted by the corporation and issued and delivered as though the person who signed
the same or whose facsimile signature shall have been used thereon had not ceased to be such officer of the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE IX </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DIVIDENDS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 40. DECLARATION OF DIVIDENDS</B>.
Dividends upon the capital stock of the corporation, subject to the provisions of the Certificate of Incorporation, if any, may
be declared by the Board of Directors pursuant to law at any regular or special meeting. Dividends may be paid in cash, in property,
or in shares of the capital stock, subject to the provisions of the Certificate of Incorporation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 41. DIVIDEND RESERVE</B>. Before
payment of any dividend, there may be set aside out of any funds of the corporation available for dividends such sum or sums as
the Board of Directors from time to time, in their absolute discretion, think proper as a reserve or reserves to meet contingencies,
or for equalizing dividends, or for repairing or maintaining any property of the corporation, or for such other purpose as the
Board of Directors shall think conducive to the interests of the corporation, and the Board of Directors may modify or abolish
any such reserve in the manner in which it was created.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE X </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FISCAL YEAR </B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 42. FISCAL YEAR</B>. The fiscal
year of the corporation shall be fixed by resolution of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE XI </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEMNIFICATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 43. INDEMNIFICATION OF DIRECTORS,
EXECUTIVE OFFICERS, OTHER OFFICERS, EMPLOYEES AND AGENTS</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) <U>DIRECTORS AND EXECUTIVE OFFICERS</U>.
The corporation shall indemnify its directors and executive officers (for the purposes of this <U>Article XI</U>, &ldquo;executive
officers&rdquo; shall have the meaning defined in Rule 3b-7 promulgated under the 1934 Act) to the fullest extent permitted by
the General Corporation Law; <U>provided</U>, <U>however</U>, the corporation may modify the extent of such indemnification by
individual contracts with its directors and executive officers; <U>provided</U>, <U>further</U>, the corporation shall not be required
to indemnify any director or executive officer in connection with any proceeding (or part thereof) initiated by such person unless
(i)&nbsp;such indemnification is expressly required to be made by law, (ii)&nbsp;the proceeding was authorized in the first instance
by the Board of Directors of the corporation, (iii)&nbsp;such indemnification is provided by the corporation, in its sole discretion,
pursuant to the powers vested in the corporation under the General Corporation Law or (iv)&nbsp;such indemnification is required
to be made under paragraph (d)&nbsp;of this <U>Section&nbsp;43</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) <U>OTHER OFFICERS, EMPLOYEES AND AGENTS</U>.
The corporation shall have power to indemnify its other officers, employees and agents to the fullest extent permitted by the General
Corporation Law.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(c) <U>EXPENSES</U>. The corporation shall
advance to any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action,
suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she is or was a
director or executive officer of the corporation, or is or was serving at the request of the corporation as a director, officer,
employee or agent of another corporation, partnership, joint venture, trust or other enterprise, prior to the final disposition
of the proceeding, promptly following request therefor, all expenses incurred by such person in connection with such proceeding
upon receipt of an undertaking by or on behalf of such person to repay said amounts if it should be determined ultimately that
such person is not entitled to be indemnified under this <U>Section&nbsp;43</U> or otherwise. Notwithstanding the foregoing, unless
otherwise determined pursuant to paragraph (e)&nbsp;of this <U>Section&nbsp;43</U>, no advance shall be made by the corporation
to an executive officer of the corporation or to any person serving at the request of the corporation as a director, officer, employee
or agent of another corporation, partnership, joint venture, trust or other enterprise, (except by reason of the fact that such
person is or was a director of the corporation in which event this paragraph shall not apply) in any action, suit or proceeding,
whether civil, criminal, administrative or investigative, if a determination is reasonably and promptly made (i)&nbsp;by the Board
of Directors by a majority vote of a quorum consisting of directors who were not parties to the proceeding, or (ii)&nbsp;if such
quorum is not obtainable, or, even if obtainable, a quorum of disinterested directors so directs, by independent legal counsel
in a written opinion, that the facts known to the decision-making party at the time such determination is made demonstrate clearly
and convincingly that such person acted in bad faith or in a manner that such person did not believe to be in or not opposed to
the best interests of the corporation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(d) <U>ENFORCEMENT</U>. Without the necessity
of entering into an express contract, all rights to indemnification and advances under this <U>Section&nbsp;43</U> shall be deemed
to be contractual rights and be effective to the same extent and as if provided for in a contract between the corporation and the
person entitled thereto. Any right to indemnification or advances granted by this <U>Section&nbsp;43</U> to such person shall be
enforceable by or on behalf of such person in any court of competent jurisdiction if (i)&nbsp;the claim for indemnification or
advances is denied, in whole or in part, or (ii)&nbsp;no disposition of such claim is made within ninety (90)&nbsp;days of request
therefor. The claimant in such enforcement action, if successful in whole or in part, shall be entitled, to the fullest extent
permitted by law, to be paid also the expense of prosecuting his or her claim. In connection with any claim for indemnification,
the corporation shall be entitled to raise as a defense to any such action that the claimant has not met the standards of conduct
that make it permissible under the General Corporation Law for the corporation to indemnify the claimant for the amount claimed.
In connection with any claim by an executive officer of the corporation or any person serving at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise (except
in any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such person
is or was a director of the corporation) for advances, the corporation shall be entitled to raise a defense as to any such action
clear and convincing evidence that such person acted in bad faith or in a manner that such person did not believe to be in or not
opposed to the best interests of the corporation, or with respect to any criminal action or proceeding that such person acted without
reasonable cause to believe that his or her conduct was lawful. Neither the failure of the corporation (including its Board of
Directors, independent legal counsel or its stockholders) to have made a determination prior to the commencement of such action
that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct
set forth in the General Corporation Law, nor an actual determination by the corporation (including its Board of Directors, independent
legal counsel or its stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the
action or create a presumption that claimant has not met the applicable standard of conduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(e) <U>NON-EXCLUSIVITY OF RIGHTS</U>. The
rights conferred on any person by this <U>Section&nbsp;43</U> shall not be exclusive of any other right which such person may have
or hereafter acquire under any statute, provision of the Certificate of Incorporation, Bylaws, agreement, vote of stockholders
or disinterested directors or otherwise, both as to action in his or her official capacity and as to action in another capacity
while holding office. The corporation is specifically authorized to enter into individual contracts with any or all of its directors,
officers, employees or agents respecting indemnification and advances, to the fullest extent permitted by the General Corporation
Law.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(f) <U>SURVIVAL OF RIGHTS</U>. The rights
conferred on any person by this <U>Section&nbsp;43</U> shall continue as to a person who has ceased to be a director, officer,
employee or agent of the corporation (or who has ceased to serve, at the request of the corporation, as a director, officer, employee
or agent of another corporation, partnership, joint venture, trust or other enterprise) and shall inure to the benefit of the heirs,
executors and administrators of such person.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(g) <U>INSURANCE</U>. To the fullest extent
permitted by the General Corporation Law, the corporation, upon approval by the Board of Directors, may purchase insurance on behalf
of any person required or permitted to be indemnified pursuant to this <U>Section&nbsp;43</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(h) <U>AMENDMENTS</U>. Any repeal or modification
of this <U>Section&nbsp;43</U> shall only be prospective and shall not affect the rights under this <U>Section&nbsp;43</U> in effect
at the time of the alleged occurrence of any action or omission to act that is the cause of any proceeding against any agent of
the corporation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(i) <U>SAVING CLAUSE</U>. If this <U>Section&nbsp;43</U>
or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the corporation shall nevertheless
indemnify each director and executive officer to the full extent permitted by any applicable portion of this <U>Section&nbsp;43</U>
that shall not have been invalidated, or by any other applicable law.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(j) <U>CERTAIN DEFINITIONS</U>. For the
purposes of this <U>Article XI</U>, the following definitions shall apply: (1)&nbsp;The term &ldquo;proceeding&rdquo; shall be
broadly construed and shall include, without limitation, the investigation, preparation, prosecution, defense, settlement, arbitration
and appeal of, and the giving of testimony in, any threatened, pending or completed action, suit or proceeding, whether civil,
criminal, administrative or investigative. (2)&nbsp;The term &ldquo;expenses&rdquo; shall be broadly construed and shall include,
without limitation, court costs, attorneys&rsquo; fees, witness fees, fines, amounts paid in settlement or judgment and any other
costs and expenses of any nature or kind incurred in connection with any proceeding. (3)&nbsp;The term &ldquo;the corporation&rdquo;
shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent)
absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify
its directors, officers, and employees or agents, so that any person who is or was a director, officer, employee or agent of such
constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or
agent of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under the
provisions of this <U>Article XI</U> with respect to the resulting or surviving corporation as he or she would have with respect
to such constituent corporation if its separate existence had continued. (4)&nbsp;References to a &ldquo;director,&rdquo; &ldquo;executive
officer,&rdquo; &ldquo;officer,&rdquo; &ldquo;employee,&rdquo; or &ldquo;agent&rdquo; of the corporation shall include, without
limitation, situations where such person is serving at the request of the corporation as, respectively, a director, executive officer,
officer, employee, trustee or agent of another corporation, partnership, joint venture, trust or other enterprise. (5)&nbsp;References
to &ldquo;other enterprises&rdquo; shall include employee benefit plans; references to &ldquo;fines&rdquo; shall include any excise
taxes assessed on a person with respect to an employee benefit plan; and references to &ldquo;serving at the request of the corporation&rdquo;
shall include any service as a director, officer, employee or agent of the corporation which imposes duties on, or involves services
by, such director, officer, employee, or agent with respect to an employee benefit plan, its participants, or beneficiaries; and
a person who acted in good faith and in a manner he or she reasonably believed to be in the interest of the participants and beneficiaries
of an employee benefit plan shall be deemed to have acted in a manner &ldquo;not opposed to the best interests of the corporation&rdquo;
as referred to in this <U>Article XI</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE XII </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 44. NOTICES</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) <U>NOTICE TO STOCKHOLDERS</U>. Whenever,
under any provisions of these Bylaws, notice is required to be given to any stockholder, it shall be given in writing, timely and
duly deposited in the United States mail, postage prepaid, and addressed to its, his or her last known post office address as shown
by the stock record of the corporation or its transfer agent, or by electronic transmission in accordance with applicable law.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) <U>NOTICE TO DIRECTORS</U>. Any notice
required to be given to any director may be given personally or by any method stated in subsection (a); provided that any notice
delivered by mail shall be sent to such address as such director shall have filed in writing with the Secretary, or, in the absence
of such filing, to the last known post office address of such director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(c) <U>AFFIDAVIT OF MAILING OR ELECTRONIC
TRANSMISSION</U>. An affidavit of mailing, executed by a duly authorized and competent employee of the corporation or its transfer
agent appointed with respect to the class of stock affected, specifying the name and address or the names and addresses of the
stockholder or stockholders, or director or directors, to whom any such notice or notices was or were given, and the time and method
of giving the same, shall in the absence of fraud, be prima facie evidence of the facts therein contained. An affidavit of the
Secretary or an Assistant Secretary or of the transfer agent or other agent of the corporation that notice has been given by a
form of electronic transmission shall, in the absence of fraud, be prima facie evidence of the facts stated therein.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(d) <U>TIME NOTICES DEEMED GIVEN</U>. All
notices given by mail, as above provided, shall be deemed to have been given as at the time of mailing, and all notices given by
electronic transmission shall be deemed to have been given as provided by applicable law.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(e) <U>METHODS OF NOTICE</U>. It shall
not be necessary that the same method of giving notice be employed in respect of all directors or stockholders, but one permissible
method may be employed in respect of any one or more, and any other permissible method or methods may be employed in respect of
any other or others.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(f) <U>FAILURE TO RECEIVE NOTICE</U>. The
period or limitation of time within which any stockholder may exercise any option or right, or enjoy any privilege or benefit,
or be required to act, or within which any director may exercise any power or right, or enjoy any privilege, pursuant to any notice
sent such stockholder or such director in the manner above provided, shall not be affected or extended in any manner by the failure
of such stockholder or such director to receive such notice.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(g) <U>NOTICE TO PERSON WITH WHOM COMMUNICATION
IS UNLAWFUL</U>. Whenever notice is required to be given, under any provision of law, the Certificate of Incorporation or these
Bylaws, to any person with whom communication is unlawful, the giving of such notice to such person shall not be required and there
shall be no duty to apply to any governmental authority or agency for a license or permit to give such notice to such person. Any
action or meeting which shall be taken or held without notice to any such person with whom communication is unlawful shall have
the same force and effect as if such notice had been duly given. In the event that the action taken by the corporation is such
as to require the filing of a certificate under any provision of the General Corporation Law, the certificate shall state, if such
is the fact and if notice is required, that notice was given to all persons entitled to receive notice except such persons with
whom communication is unlawful.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(h) <U>NOTICE TO PERSON WITH UNDELIVERABLE
ADDRESS</U>. Whenever notice is required to be given, under any provision of law or the Certificate of Incorporation or these Bylaws,
to any stockholder to whom (i)&nbsp;notice of two (2)&nbsp;consecutive annual meetings, and all notices of meetings or of the taking
of action by written consent without a meeting to such stockholder during the period between such two (2)&nbsp;consecutive annual
meetings, or (ii)&nbsp;all, and at least two (2), payments (if sent by first class mail) of dividends or interest on securities
during a twelve-month period, have been mailed addressed to such stockholder at its, his or her address as shown on the records
of the corporation and have been returned undeliverable, the giving of such notice to such stockholder shall not be required. Any
action or meeting which shall be taken or held without notice to such stockholder shall have the same force and effect as if such
notice had been duly given. If any such stockholder shall deliver to the corporation a written notice setting forth its, his or
her then current address, the requirement that notice be given to such stockholder shall be reinstated. In the event that the action
taken by the corporation is such as to require the filing of a certificate under any provision of the General Corporation Law,
the certificate need not state that notice was not given to persons to whom notice was not required to be given pursuant to this
paragraph.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(i) <U>WAIVER</U>. Whenever notice is required
to be given under any provision of the General Corporation Law, the Certificate of Incorporation or these Bylaws, a written waiver,
signed by the person entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before
or after the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a
waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting, at the beginning
of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the business
to be transacted at, nor the purpose of, any regular or special meeting of the stockholders, directors or members of a committee
of directors need be specified in any written waiver of notice or any waiver by electronic transmission unless so required by the
Certificate of Incorporation or these Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE XIII </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDMENTS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 45. AMENDMENTS</B>. Subject
to paragraph (h)&nbsp;of <U>Section&nbsp;43</U> of these Bylaws, these Bylaws may be altered or amended or new Bylaws adopted by
the affirmative vote of at least sixty-six and two-thirds percent (66 2/3%) of the voting power of all of the then-outstanding
shares of the Voting Stock. The Board of Directors shall also have the power to adopt, amend, or repeal these Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE XIV </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LOANS TO OFFICERS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 46. LOANS TO OFFICERS</B>. The
corporation may, in accordance with applicable law, lend money to, or guarantee any obligation of, or otherwise assist any officer
or other employee of the corporation or of its subsidiaries, including any officer or employee who is a director of the corporation
or its subsidiaries, whenever, in the judgment of the Board of Directors, such loan, guarantee or assistance may reasonably be
expected to benefit the corporation. The loan, guarantee or other assistance may be with or without interest and may be unsecured,
or secured in such manner as the Board of Directors shall approve, including, without limitation, a pledge of shares of stock of
the corporation. Nothing in these Bylaws shall be deemed to deny, limit or restrict the powers of guaranty or warranty of the corporation
at common law or under any statute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE XV </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORUM FOR ADJUDICATION OF DISPUTES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>SECTION 47. FORUM FOR ADJUDICATION OF
DISPUTES</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) Unless the corporation
consents in writing to the selection of an alternative forum, the sole and exclusive forum for (1)&nbsp;any derivative action
or proceeding brought on behalf of the corporation, (2)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by
any director, officer or other employee of the corporation to the corporation or the corporation&rsquo;s stockholders, (3)&nbsp;any
action asserting a claim arising pursuant to any provision of the General Corporation Law or the Certificate of Incorporation
or these Bylaws, (4)&nbsp;any action to interpret, apply, enforce or determine the validity of the Certificate of Incorporation
or these Bylaws or (5)&nbsp;any action asserting a claim governed by the internal affairs doctrine shall, in each instance, be
the Court of Chancery of the State of Delaware, or, if the Court of Chancery of the State of Delaware does not have jurisdiction,
the Superior Court of the State of Delaware, or, if the Superior Court of the State of Delaware does not have jurisdiction, the
United States District Court for the District of Delaware (the &ldquo;Delaware Forum Provision&rdquo;). The Delaware Forum Provision
shall not apply to any claims arising under the 1934 Act or the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) In addition,
unless the corporation consents in writing to the selection of an alternative forum, the federal district courts of the
United States of America shall be the sole and exclusive forum for resolving any action asserting a claim arising under the
Securities Act of 1933, as amended.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(c) If any action the subject matter of
which is within the scope of <U>Section&nbsp;47(a)</U> or <U>Section 47(b)</U> above is filed in a court other than the courts
designated in <U>Section 47(a)</U> or <U>Section 47(b)</U>, respectively, (a &ldquo;<U>Foreign Action</U>&rdquo;) in the name of
any stockholder, such stockholder shall be deemed to have consented to (1)&nbsp;the personal jurisdiction of the Court of Chancery
of the State of Delaware, the Superior Court of the State of Delaware and the United States District Court for the District of
Delaware, as applicable, in connection with any action brought in any such courts to enforce <U>Section&nbsp;47(a)</U> above, (2)&nbsp;the
personal jurisdiction of the federal district courts of the United States of America in connection with any action brought in any
courts to enforce <U>Section 47(b)</U> above (under either Section, an &ldquo;<U>Enforcement Action</U>&rdquo;), and (3)
having service of process made upon such stockholder in any such Enforcement Action by service upon such stockholder&rsquo;s counsel
in the Foreign Action as agent for such stockholder.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(d) Any person purchasing or otherwise
acquiring any interest in shares of capital stock of the corporation shall be deemed to have notice of and consented to the provisions
of this <U>Section&nbsp;47</U>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">23</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>nktr-20201215.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +a8pw7xRiXhun8uCa3NMOayPScOdypp0iZkxsGdwfenKjywqQJS2SCWcMXrWMaAI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:NKTR="http://nektartherapeutics.com/20201215" elementFormDefault="qualified" targetNamespace="http://nektartherapeutics.com/20201215">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://nektartherapeutics.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="nktr-20201215_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nktr-20201215_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>nktr-20201215_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>nktr-20201215_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nektartherapeutics.com/role/Cover" xlink:href="nktr-20201215.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nektartherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>ea132008-8k_nektartherap_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nktr-20201215.xsd" xlink:type="simple"/>
    <context id="From2020-12-15to2020-12-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000906709</identifier>
        </entity>
        <period>
            <startDate>2020-12-15</startDate>
            <endDate>2020-12-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-12-15to2020-12-15">0000906709</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-12-15to2020-12-15">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-12-15to2020-12-15">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2020-12-15to2020-12-15">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-12-15to2020-12-15">2020-12-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2020-12-15to2020-12-15">NEKTAR THERAPEUTICS</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-12-15to2020-12-15">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2020-12-15to2020-12-15">0-24006</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-12-15to2020-12-15">94-3134940</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-12-15to2020-12-15">455 Mission Bay Boulevard South</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2020-12-15to2020-12-15">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2020-12-15to2020-12-15">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2020-12-15to2020-12-15">94158</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2020-12-15to2020-12-15">(415)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-12-15to2020-12-15">482-5300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2020-12-15to2020-12-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2020-12-15to2020-12-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2020-12-15to2020-12-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2020-12-15to2020-12-15">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2020-12-15to2020-12-15">Common Stock, $0.0001     par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-12-15to2020-12-15">NKTR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-12-15to2020-12-15">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-12-15to2020-12-15">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140250531261528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 15, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 15,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-24006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NEKTAR
THERAPEUTICS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000906709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3134940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">455
Mission Bay Boulevard South<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San
Francisco<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(415)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">482-5300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001
    par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NKTR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
MY(.54=ZP^\=9!   UA   !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R-
MF-]SXC80QY\O?X6&Z</=3(A_8!*X(<P0PO687'(4<[UI.WT0M@!-;,F5Y!#^
M^ZX,L6EJUO 0+./]^J/=U:Z4P5:J9[UAS)#7-!'ZMK4Q)OOL.#K:L)3J*YDQ
M ;^LI$JI@:%:.SI3C,:%49HXONM>.RGEHC4<%/=F:CB0N4FX8#-%=)ZF5.WN
M6"*WMRVO]79CSM<;8V\XPT%&URQDYD<V4S!R2I68ITQH+@51;'7;&GF?[_RN
M-2B>^)VSK3ZZ)G8J2RF?[6 :W[9<2\02%ADK0>'KA8U9DE@EX/CG(-HJWVD-
MCZ_?U+\4DX?)+*EF8YG\Y+'9W+9Z+1*S%<T3,Y?;K^PPH0(PDHDN_I+M_MD@
M:)$HUT:F!V,@2+G8?]/7@R..##K7)PS\@X%?<.]?5%#>4T.' R6W1-FG0<U>
M%%,MK &."QN5T"CXE8.=&8[E"U,#QX"4O>%$![.[O9E_PNR>15?$ZUX2W_7=
M_YH[0%!B^"6&7^AU, SRUVBIC8) _8U(=DK)3B$9G$*440[I8\ABE[&Z&>+F
MO?8# A&4$ &J,@*"N*#XDM!U'05NOZ*)9@A'M^3HGN>,&5-<QF0B8@+Y4NN7
M!J5#Y"\^?&B(_77)=HTJCG.E"@]Q'=&$_,&H0OEPM7;;\]L=#^&Z*;EN4*6)
M,-SL "MAY"E/E_7K!-=PVWX ]1&AZ94TO7-HYFS-[1H!?SW1M-8_N,[3Y&$Q
MFE\LOD[FH]GDQV(Z#A&Z?DG7/X=N#'%4$,.IB-DK>6"[.CY<R85/W[V^<?L(
MEN=6Y<T]!VQ!7\DT!CJ^XA$M^L'ID#9(]@/(KT[0#[#D]XX*L'<.X51$4F52
M%7"7)#20_40J,I8Y^!1<*^/::#>HWT\PR*H\>_XYD*,X5DSKR[<+\@V>(]]%
M/1DN&72[%X]<%^W]CN[(G<P3]D)53$+8/6PP[*H%>'@1?X\]MB-PZD)N12TR
M+A=2<?$%UEX$E4IB@%5[\/#Z_AZP#/M,R1<NHGK'XIKC$896=0P/+_3OT692
M&UC:?_+L="[BBOW Z_8PMJIC> TMHR"#7>AI%%S@(Z!\PE"J)N'A%?Z;M$UK
MMI$"ZQ(-(D'/;W<[+EI0JD;AX17^I^+&, &N2=-<',J=KJ7"A9HV'U[5'3R\
MJ(<RX1$W7*S)(R2XXC2IY<%5FGC\JBOX> F?*=:.P#T,5MA^CPC;--B ?E^M
MZN/7H-=(5G4#'Z_7_R.;:IT#62,@+ML(>+11Q\OV@AO8#\D5\?R/RT\D9%$.
M^5;;Z!N4;'Y"[0^-C)XOR2_N%71^[X+ )X,=X M-<I2X:@(^7K47BL8V\\)=
MNI2U>=<@\/2PF&,D5;7W\<K\YBPR>8TV5*S9R3U<@]#3*+P?_88Q567>/ZO,
M3U*FUM9+OX*"V=CBD5%1'U9<\&2J.4>G5'OB?Z3VC9HD; 5"[M4-Z*K](7H_
M,#(K#JY+:> 87%QN&(5E8!^ WU=2FK>!/0N7_\H8_@M02P,$%     @ Y(.5
M48.II0/4 0  ,@8   T   !X;"]S='EL97,N>&ULU57;BM1 $/V5IC_ GD1V
M04D"*BP(*@L[#[YVDDK2T#<[E3'9K[<[G=NX#*@/HB^3.J>J3YV^3M;C).&I
M T R*JG[G':(]BUC?=6!XOTK8T'[3&.<XNBA:UEO'?"Z#X.49.GI=,\4%YH6
MF1[4@\*>5&;0F-,39476&+TSKVDD?"E70"Y<YO0#EZ)T8J[E2L@ITFD@*B.-
M(^BM0$Z3P/3/,9U$%%PN.DIHXP+)8H?X6R[E/R56U'LHI-P,IC02168Y(CC]
MX,%</),O4F2)SY/U#EO'IR2]H_N ^>.;E,;5X+8V"5VI(I/0!#M.M%WXHK$L
M)!&-\D$M>&LTGSVL(Y; RU8@Y5/8PJ_-E?;8D+@7'^NP#21,=0V]H26,,A$$
M_:-:U#[(WOV1++'B8O#]X&>C9_QM, B/#AHQSGALMOZWU)/;ZMQ:.;V3HM4*
MXMQ_N6&1\74<Z8P3S[Y;."F5)\!1<@&'HCHRWQVW9QAQ/4UC<]MS^A]Z_KOK
MW((&Q^71M#_Z__(J_XYCMMR>PQ6]NJ ;2\)#F-,OX7V5NP=2#D*BT OJ1%V#
M?G%/O3SRTC_@5_J^OH:&#Q+/6S*G>_P9:C&H-UO58UB7I6J//X7W*+F?&^[_
M$L4/4$L#!!0    ( .2#E5&7BKL<P    !,"   +    7W)E;',O+G)E;'.=
MDKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<
M'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X9
M9K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.5
M6QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,
M<6*T_C6"R0_L?@!02P,$%     @ Y(.54:K$(A8S 0  (@(   \   !X;"]W
M;W)K8F]O:RYX;6R-4=%NPC ,_)4J'[ 6M"$-45Y VY"F#8V)]]"ZU"*)*\>%
MC:^?VZH:TE[VE-S9NMQ=%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*
M0CZFL6&P9:P!Q+MTFF6SU%L,9KD8M;:<W@(2* 0I*-D1>X1+_)UW,#ECQ ,Z
ME._<]'<')O$8T.,5RMQD)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8
M,V(/'U:-Y&:6J6"%'*7?Z/6M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0]
MC.=0XIS_4R-5%1:PIJ+U$&3HD<%U!D.LL8DF"=9#;E9T!N[RZ .;<L@F:NJF
M*9ZC#GA3#O9&3R54&*!\4YFHO/93;#GICEYG>O\P>=0>6N=6RKV'5[+E&''\
MGN4/4$L#!!0    ( .2#E5$D'INBK0   /@!   :    >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*
MMR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>L
MXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X\ \PO%WHJ45D*4H5
M&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFN
MWPQP>'3^ 5!+ P04    " #D@Y5199!YDAD!  #/ P  $P   %M#;VYT96YT
M7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;
M,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:
MMB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-F<!B63R-PLQJ2AFC
M-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U
M.EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*
M$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87
M_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( .2#E5$'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ Y(.543CKM;SM    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ Y(.549E<G",0!@  G"<  !,
M         ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #D
M@Y51WK#[QUD$  #6$   &               @($,"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ Y(.548.II0/4 0  ,@8   T
M         ( !FPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #D@Y51EXJ[
M',     3 @  "P              @ &:#@  7W)E;',O+G)E;'-02P$"% ,4
M    " #D@Y51JL0B%C,!   B @  #P              @ &##P  >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ Y(.5420>FZ*M    ^ $  !H
M     ( !XQ   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ Y(.54660>9(9 0  SP,  !,              ( !R!$  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  $A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea132008-8k_nektartherap.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nektartherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea132008-8k_nektartherap.htm">ea132008-8k_nektartherap.htm</File>
    <File>ea132008ex3-1_nektartherap.htm</File>
    <File>nktr-20201215.xsd</File>
    <File>nktr-20201215_lab.xml</File>
    <File>nktr-20201215_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea132008-8k_nektartherap.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "ea132008-8k_nektartherap.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nktr-20201215_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nktr-20201215_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "nktr-20201215.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "NKTR",
   "nsuri": "http://nektartherapeutics.com/20201215",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea132008-8k_nektartherap.htm",
      "contextRef": "From2020-12-15to2020-12-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://nektartherapeutics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea132008-8k_nektartherap.htm",
      "contextRef": "From2020-12-15to2020-12-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://nektartherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001213900-20-043821-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-20-043821-xbrl.zip
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MZYKW[Q%P"=F6"88/&XXX!BF:DM9(SFE?*A$35(ND.9*+BLX)>0'>^/0R"#K
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MCWM*-)60UG*?^5>(^IUM07 Y>C>-Q2Y1[T&\NP3A/KB./J/B,*-E#E&+Z.8
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M,.\"^LCT2Q,W-#OWEP\6G9=YYT\56:>UI4C)'26QMZ.D4MN!Q7TOI>!KP@^
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M8CU?GKA?3EB4>HMKT!XRXR4M-LWCE]8=[<'X91*M#MK>\L>6#-F,?8-3.-8
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M"C-M<I3CRI%+[@QV/ME_ECWZKILUL 0/O7QXNW3W7 FJ+;YL;+*%AEP ]&"
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M75-DRXPI6A>2N5LBA?GY0SVZW;-KMB)Z;.=SOY8(T:62U&@2J5:):X&P<%'
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MEDW(+9-9:G -*RHV-1KX<SV60E6OO?:8K2#619(G;.+"C)>FJT&NZFGG I$
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ML48J:ZS1+F?R%RE'.W3,]%?9C:[6>2OVJGG!#OY:C##0R_)]Y%7Q'D"MF]E
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MX]I::^B5+ %@4U4H\4+!(^=<3#K]:E4[7F4_2")@\PG(T'H3T\?ND54G4H?
M+%<-DVBU08)2"+4DERBOMPR#G].QO7_TC3V<OR&AW='HY,("<)P8P)V]*X.:
MC7PN9HHXC:ZC;D@07#<Y"BN"^$*W-=T;)>=>Y/Z-:[^LHKRY]R(1&4NVX,6Q
M)_2<W#RGVL +ZF M)FPR#+K0=)HO!<'6K):(#&Z$4%2YKZ45AOLL#SLX<!L&
MVQ]S@(U5\J<\X.2]'>! 'M9[P _N@$^" _X[,A.84VYQ=MM;@36O5N-*$U>R
M5Q2!XTVJ@B!A'(:0C8NYD[GR&$H,P0FY&5;-.X]4_<[2& [RKD$9OA>CTA@@
M[/Y\/$:2:N$!NC_Q_!Q@!582P5 \&UT<G/W;7C7&=S1=P:AZ8[-K9A-DI1)6
M<)S6:8(D%4::N2]*:<U)E4C)N*IB#'_!H.4=F%76'#'7>J!0X0GH-#\DBV;-
MW!A>T//!OCJ5:&$:8Y^9/@-'%Q^^'@(#Z# ZGM/E5\5"E7J Z'3\K@]\*UCG
M]R/%1?V+CA!?]'5:2>/';V_9Q4*(T2;*T7YC$^7H!$\,8VLD'V$LL0\>C-Y,
M]]E0[<=5?I];O<P'*^;_YL'E]K_YFMO_*YJ/>7!I'_YZ/'J9O#P^P4X*!Z\T
MF$-7N&;2H@%?.?]O\WQ)U;K$V,M5-M2]G!P3N&;Y3IQ,JI4M=@K+'!%Q5!-O
MO]S?V$J1PW-\6^IESXUED%:/^^;)\V9F< /]A;0W(5^&>*GBQQ#_E86]L./,
M!J$&W$L&EJ?C_YD^CL.93E.&,0$!J*:W:BC,5N543(<&_% LQHZ&7@<']>=3
MGNYV?!B/[VZWS/;672Y[/R4AX:1(;#_5]]JX?O?3]F\$&MC(6.C;ATU,AU[!
MHN0!61)^NB4R,6MT.#/S/^O\X2[206OP\>,!P])A,QB?68#@\PK<?[^7'(U>
MC7XA[!8J_8,W%[^>GAU?_-O)2/85='00PE/D_=/B'-FRJG8$WPWI"I6\'ZC#
MH\5UZ^"WH ^E7.P,-#552?TI_X>VA4\?>YU)SFUK$EG3H<XD GB.8Z][3EG5
M#>V$;4OX_6$#"S>QZ_< 81X">\6:QN6&\13>@+EA?J8ZW.*F.E0^<R+%H]D5
MC=-FKF4RAA2KSP2BS$6/^#:WE"O>4\.4%=CG1SBI[>O4GN"!IH)X1GH^0[F2
M11;(;PUKR=6UYW?1VB'Q$L>&;HA;EG7^QVKJ;"@WBL!%$-*,B"G$9( <5 #M
MCP@WP]7";W,XV[\>O^3I?M"=HW/RUC>V2).\("U(*^TP19/EG+YO$RRBG?;2
MBOPRKF[!GTWE58QC/'Q8TO\L/P:%5"N8H"BJ6@> G1^IR,.<8=-\0PLA"4E@
M4I;,G#QH=7^X&,+'"A<,8+J.OT!0ES"$L!UQ>'KVV^G9P<4H.3XYOSA[\QHS
M$(@.@!%\DM$PJ:P$G]^ 14->[3]/1D?)S_].$)>N0X01?YQ!?=Z*Z\E>LG['
MUEJ!A/XNP-\&+P5O?TY):AF9H*%!FW&VUEKC%/JF?U?UK6O^J<)(+34T&P'D
M98L]0-0NG'6EJNUQ#I??+)YUO34_8XP>>9<66@%:3>C?J=@P9"$-/8T3!?9Q
M9;:PUZWMB:3/(V'DGK5ZF3:#ST\-B2\!=[N-.@B&]%Z,A YSFV2K^3.&V\W:
M#^."F4Q(8X<QA AOGP?=VJ3 TF.H[9(MPF21- [E DPAE/!IGD_9<:[A7*0$
MT&LOD7;<R4/DN$*EH,Y0\,=M/J7<=VRA7=Q85SH:5SP:)YOB[3\8M#E6I5/>
MW>X%5RN:UE'2,^K&61*_W80QBEF>L:D<LZXCFUXYA07KQ<5O;_64KW9,=#P'
M8>T&<6Q&6@ .Q$6\SSG)$O,5@3BUG#.RZTFG?]V"6FE,A6NH[?\H+3T;6-M;
MNG94YXO!XR8KI@+H<\((@NNS5"I:[#%@9M"$)E?YY*W,HLYFJ._J[(:U15:^
M;2RY&@CKLFH*AHOBWRD\9Z >(.A%--@I8Y5*48F*#@,714Q,76[7;5J7*+-$
M44V54+F+\6N<JE.DE,E:=FV&#O7VEC3'(6L5W/C)K=-DS:&F*RO[;W+W2=2%
MJ,XGUS)/<.FD,)9<"(K84\_&%A77A4[0I>'3(JV\G.?3RYSN+-V-FAL<D.M3
MH";/QG/+@F&:5M7F5]D"=^>K^Y,\?;J7]%M:H)XZII9X24AV0XK1*F(_>.TK
M9R:BJ9FZDCYQ(QJ2:MJ[>I6V"O8XG\^8^7!FS0GL@Y(WRJ*H_(F.)D;O:BKM
MEPD$5[W#+_C4^D+#&E'??A3#'B3BPN2BLHUY,./U=0SME@?+/;)YY936&/:7
M 005@MW+XPNKM=FX4/O;!Y?,_?9K,O>O(<,VMO E!A?.?STX$RS9Q>GA/QY>
MX=A3Y'D^/>...;[C/H*=?WE\"*Z[^NOGQON@:S%;@CTZ[^U>ZW;_%3 U6WJN
M4[-!DQ)SW418M>2;P<777F%DG?#:M=: 45*(?Z(^2WG#S9FTCS$:;CP3,VQL
M&6)&.A7?"Y9A1+7V#*ZSKMC ).,<V6R*NA]T3&];-$31@%C0X XUS>_ANGG>
M6B31:] )<=_-Q:'Q#&_5V;+U7.K-WCC^AJYKT0T2N)$)<(V4<J;C$P](H@_)
M:#"=([2;AOYP;0B$[+?E<@Y_!GM^>XNJQPZL>"D"4YW.QE NNB*A]23:W@P;
MWY=,S>^D,U,FU)GE)H%)1)R7,. Z(Q8DQ/ WCFO/'=3-8YU(C*E6( *A*0=B
M OFS/M($R>^TN8%/NA ,B23!CDE:D3$'C_/L E>[6:$E6[0Z??Z-7?@F,PDR
MVIY9<L61?_C/35[WC61[*[8ZDE)0WD5ZUWV3 7UB[?Y\+WEU>G[15>;)P?96
M"6]Q=PA!55Z\J8ZKP&#SBM(GQ!MZI+@W*"'(!T+?CWA9((7YI:,E26SG58,4
M&6TUSSD6.L7.'N#;3U,;5%QD;Y57OZ34UC2[UL@(R,,,W7=^H0ELP'4 1T4C
M0?[)9XW"AZ#__0P(<B?@4%RGS*0):H9+9HF9/S>(%GPI+D1F^$;?=UOXID1E
M:NG0^L?L/I-.L/L.YC?!>FP'<(,@C+F]YBAC2!'S;'J-WQ6^53K"JF=M9,Q4
M'"OS-X='".I.N^'M?X)W3 M25I73"(Z.XB3R5!=JW6A?.NQ;<)EAI)!%$K>8
M)4!D=Y%A^9E\I//^L-M=*!EWE,^O$9WDZ3=P2,X.3LY?/N2ZW0NYKQI.45,E
M23>J;VB*HB8,22XAXTCIH=W*J%?1HUK0TFJ/1=M<5]+JX,S697[+!;PVCL3F
M'SZ4(SEP!"5X26J)0;)8\JO)@R$E12'-9%Z\C=A[.T[TB0P>^).OT0C30RHM
MTO?0VEZ8V-E]>((D'$E=Z2!=Q('M%@Q#)U'H@D8ITGQ9YQR]YB7U:!:\NBAU
MG1QN!^,_#5C<^'[MO,7 #C4:8UFL2-YBX+6>N^ -5F*O"N3&1(\E?5C3L.&K
MDDZ>?KN7O#S^%X;=ST:'IV='R9'C_1^7 BFG>S3<,.:X=A/TWLZXCJ\EI@UX
MJ7W!DYP(-Q!=L+VD.JTG6<2$X.]8;4RON9=3IIH6'8%4<'K.KQQ\G)AFUFT0
M>!%^@XP$)\@ [U&CT7T8DMQA^XYAPASFU^D?".IY;N@,9FQ3O -[9N>;Q\)8
M56).3*K<X<\(L-K9?^ST@TXB[:"]KNK"XA7-X%7$7$+D[[1>W"S"#H]@UI@<
M#6<^(Y.')4!7IE<&"&D6-'MW:_<C(S/216VZG0;H8 3RD 7YZ&PVB:H".*="
MQE_5L05B3 D/Q"O&-Y,3WX(7)%=^?X8OP(*652@(A@*F3PS6+>$&1ZAB7:_K
MF?6>)S,G/;SSBJ]>4\QO^A3<<OM=/@VZE?AK<QA"K"QY$,7,^?U-5E!KM@_Q
M-G=KX-&8FT-&8V\/R&@*;RY9VX&52S9=.+0Z;A5=[BBE0'1>$*/XA@'-J/(2
M#S 4"UH4=\*=<>HLR:W4:5&&CT=+?/3203)SW"HRP9RS36-HHK*Y@3PR9J#S
M2NL:DEY/\JR>%WHFZ6U9F]@6T)O-U.R?;R7B)8%F#;6&C2[ IP!Y?N*K^SL$
M#/]R?'XQ.AL=<3;CU]-71^IM,=@NZE"XJXD;?EEJBZ_\W60.Q_5:,-[B![ O
MP6&VG+JANEZ(2(X-0["MQ_8@X?$3ZO4!7H2R@JNTB@*GKZ9.88]<B&-P^H-!
MXEG$<$)+WH!)Q8N[7W$4'0?9M(1;9HL11\1!Q<R)SF+^WIB=#D P;$!A AED
M;4MC,/MNG\#?0.\R!]J&W8*%(E[N!JWDIWAZ*Q?240Z_AA$^U*3X=P\N*?[=
MUZ3X7T.&G:3XEY@5YU9Z+NSJ98BW>H"9\N\#9'NX2G+/(@8-P]8$,![#TR@%
M& ,&#Y95I_)Q]@ I3.(%V'8FR%'.Z9>0O_CI,S0T=U-3*63SRIMFC#=*%U-)
MCBVF%6":[>KL0-36^,)=$&Y2+.AFU3([]MLR)[.I3JWY--.WZ:>9-PZ6RN79
MM-G0#KD*VZ71!+;6:O?45G>QS;&$^2:> 0/T31$?BI$C18Z!$\K0K>/>P:JC
M23=Q27MAMU?9' P@BX1F[JQ:6EG"> F<VLT;IVSV$48^STTE7\)'!8?E-E5B
MAZUG]."CK1V^YHC#%/K, 3]ROEO;A_$FQZ'<:-S9P6QO;;:6(K^4FC-RY0E>
M=W1<?L;#PU2^6)V3"D-(U <43F]&;CU7\[_')J?=S;4;XT+4'="I?_1]^$9<
M4'M@Y)N=]'7]K\#OLVNJ 3TVP&.8!7]AHQ ):@7E=CTU4 @]_?3IOF6VB3]W
MG0>!%"8@@)-QE)/4!=& "U\ TD%HA:EG=.-2=SK\56S:'<+6?%[0G9%&)<\I
M-HB\@DCVX(\4H=-M]P.=(4A&\OM<H26O9O^0F%?L>>8MI E(ZDD"!>OVP,YM
MY5X45QDW%>S%L$1$_ OSLM1"/?[7%VB?@I^!W)-'#Y#H_]ECI-8X?'5P9K@U
MS&J( 7JDX16GU&X-5'--G]YUD#AI&7!+A5-@:V&D<C+/!NNL/:L!.YE+Y;JV
M*<0;Q^]O!Q,W,].6U5B.5="=<,6);DI2@P;G@'3II!H[Z_ G)_TE,VVZ K>_
M9R0,&4%&9[^/&$'V<\XPKF5VJX%P;M'(FY2R.M:M:G(,@E%OI97Y+!>QQ>IK
MK[-B;LJE3,!0#/[5@@V2!88;^<:("%BDNSN##@KJUH1YO-RK+\8BL[=*!D:@
M+40Z87,:@A72/QMNVIBW5 T&4IF#+Y WMA@H)Q;T_Z YZL0YY8]U#A)+58>4
M3@(C@2W"1%AH2';CSB _P#7"I'Z, ZZQDDUM1$W30OS9:D)H*P&=B8727\@Z
MD*=85%,0.[(VQM6\:*Z82$>I1VC1_*8'AB&E:).;K-'>S%_HM?LEWKHOC\\/
M#UXE_QX=G/7,[J'A)9X]0;R$6156BYAGF8%607?[%CV$(3"7R1!O4K;WL<Z*
M+-3]'98O,89Z?'(T>GW"F.L'&2]]]A3<]6 1W&Z=<&5*./7WD>GHDDI4U?X\
M>OW;J]-_CT;$\I(<_&+H0^Z+Z_?3M7@Q2^469SF+Y5"FQKIY$1 :+FFF47')
MO3N-)9ID1S$&8E:(55 T.) #L((G8(O]ZYC#E'^;3_]W5;TPC[%\3'^KZ2\A
MM>@BS\C,F>8SXO  8^!L!0]\.G[T+1%SK.:7%-'BZ")^9?_[I\^2@TF[J_;*
M;#6?8T %%@RM38I:MAQ]8!.P!]>W8859B&43"X?3X*W8MQ+:X95%MP _C>]'
M;A-X ?81LYPL!*W<9/7C0Y0^[O$A>IEQY3JAP*+=>*]A.IJFG7XB3"Y?2J,/
M P6U?/:(U>7,N"2T=^$[15MH^-$)SIF>/SN%0-&BJP42)3GSN2F1T! -09N5
MKV6GT.>(;Z9#0NO1"3B*F3DK:DKR-T*&-\ H$3%WX67K1AWF['W_ER$0<(=[
M+@4X1XZ72_-@^LIKCM!UB]R<$] CS[B3.\7UFM%Z(J%+R\]V>F!.;0],/>M>
M(NG94](Q#XA6_?L'!SKX_BOHX*]H(G#;K<VLI0$SP2L9"(P&O[UD:JATO$Z3
MZV]G5YEM;WT6J/O[;Z<T^M=OHY/SD>V>U-T;1%$2A%U1ITZR!._ BANPT_5\
M*S^U5Q16*?TK53\CS[$?2N&9S,I6<:?+>4[YLHG<7LV*>8SL[9L:.-P$#)YY
MFDQJ+)XDOK(IHI:Q])9M##0O\)XK+C,N%1QK9SV]@JD:DY"?MLJ7ZPWICM_>
M&K9>>N)D]@D8AZ+HFC+R@FYKHC19%.W3MZ6FP'A[R]!'5;5R2F'HLD,CE-(2
M@XPW5\4R3?Z@QJ_7G%A+.4=K,WBDY)9U@2RL2R0T-:<(5Q(-".+Z4E2S;_\P
MD]VR!?-I5LWGU0W.4*=&5MJLDM:W8&CE94.<1).5TIZZ)EO$_N,_F[=M;U$2
M@:";2YD\VQ$MH^&9J\"C'W3?0'#-)=C3Q)S&A9M4UTTPRFJ%+$NY2^^WFK?%
M J03P=97"//WQMN0R>LB5JFH7\P?QX'H-68\EL"]Y,3G ^==@.OLLJ*E5IO6
M\@HZ0W5M.\>HRC<RJHBN3 ^X7]S7-3 %,;!91\"J#A3&GSX&1O,S:N!C'(,=
MP<D.Z B/C<Y1$XZ/$^W!X1-SHR5O]LIZ403OW]4",E& 243_;6^]OP+$+%D
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MH]P2=?*V(!Y$ 4>M1</#>CWM6:] !<JR:6]Z(WW$2RM] +1]>MX@Y@DV/"C
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MJYC .-K4$GNJ&?B/) J)()9@-;9G,\:3G)M=*;'Q]XUWY:NE FZK-3W(#7,
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M&5+@HO*^<V8GM^7R0DF.01"-'I&5O""C=P;$_Q1#Q!YI!,L7<CS\%L-9RON
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MM?GF8/Y??9^O/ISW_WT/?WRZ/#UY_P-02P,$%     @ Y(.544<-D^Y" P
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M9 4G";8'_-W1"QI?+,"""T_<#!Y*.$ HF%'Z2/9BZ70AAR*%6H?K8#X4JFE
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M3:M&; XR_Z!I>.M"1@;(=8X,<0]+MNRZX_><O40T@!?4D-P)-H!I(SN:UC^
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M=&AE<F%P+FAT;5!+ 0(4 Q0    ( .2#E5$ J;R&JX,  "K? @ >
M      "  2$2  !E83$S,C P.&5X,RTQ7VYE:W1A<G1H97)A<"YH=&U02P$"
M% ,4    " #D@Y511PV3[D(#  "D#   $0              @ $(E@  ;FMT
M<BTR,#(P,3(Q-2YX<V102P$"% ,4    " #D@Y51EE1Y\O@*  #6AP  %0
M            @ %YF0  ;FMT<BTR,#(P,3(Q-5]L86(N>&UL4$L! A0#%
M  @ Y(.54=H[JJ=:!P  /UD  !4              ( !I*0  &YK='(M,C R
C,#$R,35?<')E+GAM;%!+!08     !0 % %L!   QK      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
